+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 46972

Chapter 46972 provides scholary research titles of which PDF Full Texts are available through EurekaMag.





Carr, B.I.; Zajko, A.; Bron, K.; Orons, P.; Sammon, J.; Baron, R., 1997:
Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysis

Itoh, K.; Tsukamoto, E.; Kakizaki, H.; Nonomura, K.; Koyanagi, T.; Furudate, M.; Torizuka, K., 1993:
Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases

Caponigro, F.; Dittrich, C.; Sorensen, J.B.; Schellens, J.H.M.; Duffaud, F.; Paz Ares, L.; Lacombe, D.; de Balincourt, C.; Fumoleau, P., 2001:
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer

Twelves, C.; Campone, M.; Coudert, B.; Van den Bent, M.; de Jonge, M.; Dittrich, C.; Rampling, R.; Sorio, R.; Lacombe, D.; de Balincourt, C.; Fumoleau, P., 2002:
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme

Meropol, N.J.; Pazdur, R.; Vincent, M.; Willson, J.K.; Kelsen, D.P.; Douglass, H.O., 1996:
Phase II study of ZD1694 in patients with advanced gastric cancer

Planting, A.S.; de Wit, R.; van der Burg, M.E.; Stoter, G.; Verweij, J., 1996:
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma

Wagenaar, H.C.; Pecorelli, S.; Vergote, I.; Curran, D.; Wagener, D.J.; Kobierska, A.; Bolis, G.; Bokkel-Huinink, W.T.; Lacave, A.J.; Madronal, C.; Forn, M.; de Oliveira, C.F.; Mangioni, C.; Nooij, M.A.; Goupil, A.; Kerbrat, P.; Marth, C.H.; Tumolo, S.; Herben, M.G.; Zanaboni, F.; Vermorken, J.B., 2001:
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer

Sugita, T.; Matsunaga, K.; Kobayashi, H.; Horikawa, S.; Suzuki, Y.; Nishiyama, H.; Maekawa, N.; Matsumoto, H.; Okazaki, M.; Katagami, N., 1994:
Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer

Feliu, J.; Mel, R.; Borrega, P.; López Gómez, L.; Escudero, P.; Dorta, J.; Castro, J.; Vázquez-Estévez, S.E.; Bolaños, M.; Espinosa, E.; González Barón, M., 2002:
Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas

Shaughnessy, P.J.; Ornstein, D.; Ririe, D.; Callander, N.; Anderson, J.E.; Pollack, M.S.; Freytes, C.O.; Cruz, J.; Rodriquez, T.; Bachier, C.; LeMaistre, C.F., 2002:
Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience

Sakurai, M.; Ichiki, M.; Ohashi, Y.; Hayashi, I., 1993:
Phase II study of a novel combination regimen composed of cisplatin, carboplatin and etoposide against unresectable non-small cell lung cancer

Evans, W.K.; Earle, C.C.; Stewart, D.J.; Dahrouge, S.; Tomiak, E.; Goss, G.; Logan, D.; Goel, R.; Gertler, S.Z.; Dulude, H., 1997:
Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer

Planting, A.S.; van der Burg, M.E.; Goey, S.H.; Schellens, J.H.; van den Bent, M.J.; de Boer-Dennert, M.; Stoter, G.; Verweij, J., 1995:
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma

Hartung, G.; Hofheinz, R.D.; Wein, A.; Riedel, C.; Rost, A.; Fritze, D.; Kreuser, E.D.; Drees, M.; Kühnel, J.; Hehlmann, R.; Queisser, W., 2001:
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer

Yang, T.S.; Hsu, K.C.; Wang, H.M.; Lin, Y.C., 2002:
Phase II study of a weekly 8-hour 5-fluorouracil and leucovorin infusion for patients with advanced colorectal cancer: dose adjusted according to its toxicity

Athanasiadis, I.; Kies, M.S.; Miller, M.; Ganzenko, N.; Joob, A.; Marymont, M.; Rademaker, A.; Gradishar, W.J., 1995:
Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer

Westeel, V.; Jacoulet, P.; Breton, J.L.; Garnier, G.; Mercier, M.; Depierre, A., 1996:
Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience

Alberto, P., 1993:
Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer

Brett, B.T.; Smith, S.C.; Bouvier, C.V.; Michaeli, D.; Hochhauser, D.; Davidson, B.R.; Kurzawinski, T.R.; Watkinson, A.F.; Van Someren, N.; Pounder, R.E.; Caplin, M.E., 2002:
Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer

Borner, M.M.; Dietrich, D.; Stupp, R.; Morant, R.; Honegger, H.; Wernli, M.; Herrmann, R.; Pestalozzi, B.C.; Saletti, P.; Hanselmann, S.; Müller, S.; Brauchli, P.; Castiglione-Gertsch, M.; Goldhirsch, A.; Roth, A.D., 2002:
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

Kim, T.W.; Kang, Y.K.; Ahn, J.H.; Chang, H.M.; Yook, J.H.; Oh, S.T.; Kim, B.S.; Lee, J.S., 2002:
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer

Vieitez, J.M.; Valladares, M.; Gracia, M.; Gonzalez-Barón, M.; Martín, G.; Mel, J.R.; Rodríguez, R.; Constenla, M.; Gómez Aldavarí, J.L.; Domínguez, S.; Dorta, J.; García-Girón, C.; López, R.; Sevilla, I.; Esteban, E.; Antón, L.M.; Peláez, I.; López, E.; Lacave, A.J., 2002:
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Falk, S.J.; Maughan, T.S.; Laurence, V.M.; Lamont, A.; Boote, D.; Ford, J.M.; Osborne, R.J.; Bleehen, N.M., 1993:
Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer

Dutcher, J.P.; Lee, S.; Paietta, E.; Bennett, J.M.; Stewart, J.A.; Wiernik, P.H., 1998:
Phase II study of carboplatin in blast crisis of chronic myeloid leukemia: Eastern Cooperative Oncology Group Study E1992

Gururangan, S.; Cavazos, C.M.; Ashley, D.; Herndon, J.E.; Bruggers, C.S.; Moghrabi, A.; Scarcella, D.L.; Watral, M.; Tourt-Uhlig, S.; Reardon, D.; Friedman, H.S., 2002:
Phase II study of carboplatin in children with progressive low-grade gliomas

van Wijk, F.H.; Lhommé, C.; Bolis, G.; Scotto di Palumbo, V.; Tumolo, S.; Nooij, M.; de Oliveira, C.F.; Vermorken, J.B., 2002:
Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

Rougier, P.; Zarba, J.J.; Ducreux, M.; Basile, M.; Pignon, J.P.; Mahjoubi, M.; Benahmed, M.; Droz, J.P.; Cvitkovic, E.; Armand, J.P., 1993:
Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma

Feliu, J.; González Barón, M.; García Girón, C.; Espinosa, E.; Vicent, J.M.; Gómez Navarro, J.; Berrocal, A.; Ordóñez, A.; Vilches, Y.; de Castro, J.; Díaz, J., 1996:
Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain

Frappaz, D.; Bouffet, E.; Perel, Y.; Stephan, J.L.; Alos, N.; Grabois, M.; Berger, C.; Brunat Mentigny, M.; Philip, T., 1997:
Phase II study of cisplatinum and carboplatinum (CACIS) combination in advanced stage neuroblastomas

Sakurai, M.; Ichiki, M.; Hayashi, I., 1997:
Phase II study of combination chemotherapy with cisplatin, carboplatin and etoposide (CPVP) in unresectable non-small cell lung cancer: analysis of survival time and prognostic factors

Rosenthal, M.A.; Gruber, M.L.; Glass, J.; Nirenberg, A.; Finlay, J.; Hochster, H.; Muggia, F.M., 2000:
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme

Nakata, Y.; Yamada, T.; Itoh, R.; Koishi, K.; Hiraoka, K.; Yamagami, K.; Itani, Y.; Toyoda, S.; Itoh, K.; Kimura, T.; Hosokawa, K.; Honjo, H.; Fujita, H.; Koshiba, H.; Hara, Y.; Tsuchiya, H.; Adachi, S., 2002:
Phase II study of combination therapy with paclitaxel and carboplatin against postoperative small residual disease in patients with stage I c-IV ovarian cancer--KCOG 989 trial

Hauns, B.; Häring, B.; Köhler, S.; Mross, K.; Unger, C., 2001:
Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer

Mori, K.; Kamiyama, Y.; Kondoh, T.; Tominaga, K., 2002:
Phase II study of combined Vinorelbine (Navelbine) plus cisplatin for advanced non-small cell lung cancer (an interim report)

Kubota, K.; Tamura, T.; Fukuoka, M.; Furuse, K.; Ikegami, H.; Ariyoshi, Y.; Kurita, Y.; Saijo, N., 2000:
Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902

Hartmann, J.T.; Kanz, L.; Bokemeyer, C., 2000:
Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma

Lopez, M.; Carpano, S.; Cancrini, A.; Marcellini, M.; Del Medico, P.; Rinaldi, M.; Vici, P.; Paoletti, G.; D.L.uro, L., 1993:
Phase II study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma

Palumbo, R.; Palmeri, S.; Antimi, M.; Gatti, C.; Raffo, P.; Villani, G.; Toma, S., 1998 :
Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas

Warner, E.; Hedley, D.; Andrulis, I.; Myers, R.; Trudeau, M.; Warr, D.; Pritchard, K.I.; Blackstein, M.; Goss, P.E.; Franssen, E.; Roche, K.; Knight, S.; Webster, S.; Fraser, R.A.; Oldfield, S.; Hill, W.; Kates, R., 1998:
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen

Stopeck, A.T.; Jones, A.; Hersh, E.M.; Thompson, J.A.; Finucane, D.M.; Gutheil, J.C.; Gonzalez, R., 2001:
Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma

Latreille, J.; Cormier, Y.; Martins, H.; Goss, G.; Fisher, B.; Eisenhauer, E.A., 1996:
Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer

Niho, S.; Ohe, Y.; Kakinuma, R.; Kubota, K.; Matsumoto, T.; Ohmatsu, H.; Goto, K.; Nishiwaki, Y., 2002:
Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer

Kim, Y.H.; Kim, J.S.; Choi, Y.H.; In, K.H.; Park, H.S.; Hong, D.S.; Jeong, T.J.; Lee, Y.Y.; Nam, E.; Lee, S.N.; Lee, K.S.; Kim, H.K., 2002:
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer

Specht, L.; Larsen, S.K.; Hansen, H.S., 2000:
Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

Amodio, A.; Carpano, S.; Paoletti, G.; Gionfra, T.; Rinaldi, M.; Manfredi, C.; Foggi, P.; Lopez, M., 1998:
Phase II study of docetaxel in patients with advanced stage soft tissue sarcoma

Kavanagh, J.J.; Kudelka, A.P.; de Leon, C.G.; Tresukosol, D.; Hord, M.; Finnegan, M.B.; Kim, E.E.; Varma, D.; Forman, A.; Cohen, P.; Edwards, C.L.; Freedman, R.S.; Verschraegen, C.F., 1996:
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum

Coleman, R.E.; Howell, A.; Eggleton, S.P.; Maling, S.J.; Miles, D.W., 2000:
Phase II study of docetaxel in patients with liver metastases from breast cancer. UK study group

Mattson, K.; Bosquee, L.; Dabouis, G.; L.G.oumellec, A.; Pujol, J.L.; Marien, S.; Stupp, R.; Douillard, J.Y.; Brägas, B.; Berille, J.; Olivares, R.; L.C.evalier, T., 2000:
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice

Savarese, D.M.; Halabi, S.; Hars, V.; Akerley, W.L.; Taplin, M.E.; Godley, P.A.; Hussain, A.; Small, E.J.; Vogelzang, N.J., 2001:
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B

Krug, L.M.; Miller, V.A.; Kalemkerian, G.P.; Kraut, M.J.; Ng, K.K.; Heelan, R.T.; Pizzo, B.A.; Perez, W.; McClean, N.; Kris, M.G., 2000:
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

Vaishampayan, U.; Glode, M.; Du, W.; Kraft, A.; Hudes, G.; Wright, J.; Hussain, M., 2000:
Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma

Meredith, R.F.; Khazaeli, M.B.; Plott, W.E.; Grizzle, W.E.; Liu, T.; Schlom, J.; Russell, C.D.; Wheeler, R.H.; LoBuglio, A.F., 1996:
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer

Kobayashi, H.; Kawai, S.; Sakayori, S.; Kaneko, M.; Ito, Y.; Ujike, Y.; Kobayashi, K.; Imaizumi, H.; Hoshi, S.; Endo, S., 1994:
Phase II study of edobacomab (E5) in the treatment of gram-negative sepsis

Nisticò, C.; Garufi, C.; Barni, S.; Frontini, L.; Gallà, D.A.; Giannarelli, D.; Vaccaro, A.; D'Ottavio, A.M.; Terzoli, E., 1999:
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer

Parnis, F.X.; Olver, I.N.; Kotasek, D.; Norman, J.; Taylor, A.; Russell, J.; Patterson, K.; Keefe, D.; Marafioti, T., 2000:
Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site

Cripps, C.; Burnell, M.; Jolivet, J.; Batist, G.; Lofters, W.; Dancey, J.; Iglesias, J.; Fisher, B.; Eisenhauer, E.A., 1999:
Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study

Tsimberidou, A.M.; O'Brien, S.M.; Cortes, J.E.; Faderl, S.; Andreeff, M.; Kantarjian, H.M.; Keating, M.J.; Giles, F.J., 2002:
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders

Epelbaum, R.; Rosenblatt, E.; Nasrallah, S.; Faraggi, D.; Gaitini, D.; Mizrahi, S.; Kuten, A., 2002:
Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer

von Minckwitz, G.; Bauknecht, T.; Visseren-Grul, C.M.; Neijt, J.P., 1999:
Phase II study of gemcitabine in ovarian cancer

Sekine, I.; Nishiwaki, Y.; Kakinuma, R.; Kubota, K.; Hojo, F.; Matsumoto, T.; Ohmatsu, H.; Yokozaki, M.; Goto, K.; Miyamoto, T.; Takafuji, J.; Kodama, T., 1997:
Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413

Novello, S.; Galli, L.; Antonuzzo, A.; Crinó, L.; Pozzi, E.; Selvaggi, G.; Ricci, S.; Marrocolo, F.; Darwish, S.; Sorbolini, S.; Tonato, M.; Scagliotti, G.V., 2001:
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer

Wilailak, S.; Tresukosol, D.; Linasmita, V.; Termrungruanglert, W., 2001:
Phase II study of high-dose paclitaxel in platinum-refractory epithelial ovarian cancer

Marschke, R.F.; Grill, J.P.; Sloan, J.A.; Wender, D.B.; Levitt, R.; Mailliard, J.A.; Gerstner, J.B.; Ghosh, C.; Morton, R.F.; Jett, J.R., 1999:
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer

Ali, M.A.; Kraut, M.J.; Valdivieso, M.; Herskovic, A.M.; Du, W.; Kalemkerian, G.P., 1998:
Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer

Thongprasert, S., 2000:
Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer

Lichtman, S.M.; Niedzwiecki, D.; Barcos, M.; Carlisle, T.L.; Cooper, M.R.; Johnson, J.L.; Peterson, B.A., 2000:
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B

Gridelli, C.; Perrone, F.; D'Aprile, M.; Rossi, A.; Palmeri, S.; Curcio, C.; Veltri, E.; Ianniello, G.; Lorusso, V.; Palmieri, G., 1995:
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer

Meredith, R.F.; Khazaeli, M.B.; Macey, D.J.; Grizzle, W.E.; Mayo, M.; Schlom, J.; Russell, C.D.; LoBuglio, A.F., 1999:
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer

Baars, J.W.; Wagstaff, J.; Van Groeningen, C.J.; Vermorken, J.B.; Bijvank, E.M.; Pinedo, H.M.; Nauta, J.J., 1993:
Phase II study of interferon-gamma and interleukin-2: tachyphylaxis of toxicity to the liver during increasing immune enhancement

Lümmen, G.; Goepel, M.; Möllhoff, S.; Hinke, A.; Otto, T.; Rübben, H., 1996:
Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma

Vlasveld, L.T.; Horenblas, S.; Hekman, A.; Hilton, A.M.; Dubbelman, A.C.; Melief, C.J.; Rankin, E.M., 1994:
Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer

Dropcho, E.J.; Rosenfeld, S.S.; Vitek, J.; Guthrie, B.L.; Morawetz, R.B., 1998:
Phase II study of intracarotid or selective intracerebral infusion of cisplatin for treatment of recurrent anaplastic gliomas

Hoff, P.M.; Ellerton, J.A.; Dakhil, S.R.; Winn, R.J.; Abbruzzese, J.L.; Pazdur, R., 2001:
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinoma

Verschraegen, C.F.; Levenback, C.; Vincent, M.; Wolf, J.; Bevers, M.; Loyer, E.; Kudelka, A.P.; Kavanagh, J.J., 2001:
Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan

Oh, Y.; Perez-Soler, R.; Fossella, F.V.; Glisson, B.S.; Kurie, J.; Walsh, G.L.; Truong, M.; Shin, D.M., 2000:
Phase II study of intravenous Doxil in malignant pleural mesothelioma

Case, D.C.; Gerber, M.C.; Gams, R.A.; Crawford, J.; Votaw, M.L.; Higano, C.S.; Pruitt, B.T.; Gould, J., 1993:
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma

Watanabe, N.; Miyagawa, I.; Higasibori, Y.; Nakahara, T.; Sumi, F.; Ishida, G.; Abe, B.; Inoue, A.; Hanamoto, N., 1994:
Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors. Tottori University Oncology Group

Turner, C.D.; Gururangan, S.; Eastwood, J.; Bottom, K.; Watral, M.; Beason, R.; McLendon, R.E.; Friedman, A.H.; Tourt-Uhlig, S.; Miller, L.L.; Friedman, H.S., 2002:
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience

Takeda, K.; Takifuji, N.; Uejima, H.; Yoshimura, N.; Terakawa, K.; Negoro, S., 2002:
Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer

Kudoh, S.; Fujiwara, Y.; Takada, Y.; Yamamoto, H.; Kinoshita, A.; Ariyoshi, Y.; Furuse, K.; Fukuoka, M., 1998:
Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group

Furukawa, H.; Hiratsuka, M.; Imaoka, S.; Ishikawa, O.; Kabuto, T.; Sasaki, Y.; Kameyama, M.; Ohigashi, H.; Nakano, H.; Yasuda, T.; Murata, K., 1999:
Phase II study of limited surgery for early gastric cancer: segmental gastric resection

Verweij, J.; Judson, I.; Steward, W.; Coleman, R.; Woll, P.; van Pottelsberghe, C.; van Glabbeke, M.; Mouridsen, H., 1994:
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study

Stewart, D.J.; Eapen, L.; Girard, A.; Verma, S.; Genest, P.; Evans, W.K., 1993:
Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases

Smorenburg, C.H.; Seynaeve, C.; Bontenbal, M.; Planting, A.S.; Sindermann, H.; Verweij, J., 2001:
Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients

Wiernik, P.H.; Moore, D.F.; Bennett, J.M.; Vogl, S.E.; Harris, J.E.; Luger, S.; Oken, M.M.; Glick, J.H., 1998:
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481)

Kikuyama, S.; Inada, T.; Oyama, R.; Ogata, Y., 2003 :
Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer

Pusztai, L.; Holmes, F.A.; Fraschini, G.; Hortobagyi, G.N., 1999:
Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy

Mammoliti, S.; Merlini, L.; Caroti, C.; Gallo, L., 1996:
Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients

Grossi, F.; Pennucci, M.C.; Serrano, J.; Frola, C.; Mereu, C.; Scolaro, T.; Ratto, G.B.; Tixi, L.; Ardizzoni, A., 2003:
Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer

Buzaid, A.C.; Colome, M.; Bedikian, A.; Eton, O.; Legha, S.S.; Papadopoulos, N.; Plager, C.; Ross, M.; Lee, J.E.; Mansfield, P.; Rice, J.; Ring, S.; Lee, J.J.; Strom, E.; Benjamin, R., 1999:
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

Pujol, J.L.; Monnier, A.; Berille, J.; Cerrina, M.L.; Douillard, J.Y.; Rivière, A.; Grandgirard, A.; Gouva, S.; Bizzari, J.P.; L.C.evalier, T., 1994:
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer

van der Gaast, A.; Henzen-Logmans, S.C.; Planting, A.S.; Stoter, G.; Verweij, J., 1993:
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site

Cartwright, T.H.; Cohn, A.; Varkey, J.A.; Chen, Y-Miao.; Szatrowski, T.P.; Cox, J.V.; Schulz, J.J., 2002:
Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer

Lin, J.K.; Wang, W.S.; Hsieh, R.K.; Hsu, T.C.; Chiou, T.J.; Liu, J.H.; Fan, F.S.; Yen, C.C.; Lin, T.C.; Jiang, J.K.; Yang, S.H.; Wang, H.S.; Chen, P.M., 2001 :
Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience

White, S.C.; Cheeseman, S.; Thatcher, N.; Anderson, H.; Carrington, B.; Hearn, S.; Ross, G.; Ranson, M., 2000:
Phase II study of oral topotecan in advanced non-small cell lung cancer

Freyer, G.; Delozier, T.; Lichinister, M.; Gedouin, D.; Bougnoux, P.; His, P.; Imadalou, K.; Trillet-Lenoir, V., 2002:
Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy

Zelek, L.; Cottu, P.; Tubiana-Hulin, M.; Vannetzel, J-M.; Chollet, P.; Misset, J-L.; Chouaki, N.; Marty, M.; Gamelin, E.; Culine, S.; Dieras, V.; Mackenzie, S.; Spielmann, M., 2002:
Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients

Monnet, I.; Brienza, S.; Hugret, F.; Voisin, S.; Gastiaburu, J.; Saltiel, J.C.; Soulié, P.; Armand, J.P.; Cvitkovic, E.; de Cremoux, H., 1998:
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques

Louvet, C.; André, T.; Tigaud, J.M.; Gamelin, E.; Douillard, J.Y.; Brunet, R.; François, E.; Jacob, J.H.; Levoir, D.; Taamma, A.; Rougier, P.; Cvitkovic, E.; de Gramont, A., 2002:
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

Noda, K.; Ikeda, M.; Kudo, R.; Nishiya, I.; Yajima, A.; Tanaka, K.; Kodama, S.; Takahashi, T.; Tokunaga, A.; Satoh, I.; Nozawa, S.; Taketani, Y.; Terashima, Y.; Isonishi, S.; Takeda, Y.; Nishijima, M.; Kuroshima, Y.; Fujii, S.; Izumi, R.; Tamaya, T.; Mori, T.; Okada, H.; Ogita, S.; Ozaki, M.; Hatae, M., 1996:
Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion

Ito, Y.; Horikoshi, N.; Watanabe, T.; Sasaki, Y.; Tominaga, T.; Okawa, T.; Tabei, T.; Kuraishi, Y.; Tamura, K.; Abe, R.; Kitajima, M.; Yamaguchi, S.; Kobayashi, T.; Koyama, H.; Orita, K.; Takashima, S.; Nomura, Y.; Ogawa, M., 1998:
Phase II study of paclitaxel (BMS-181339) intravenously infused over 3 hours for advanced or metastatic breast cancer in Japan. BMS-181339 Breast Cancer Study Group

Chen, C-Hung.; Chang, W-Cheng.; Lin, M-Chin.; Hsu, J-Wen.; Chao, T-Yi.; Tsao, T.C.Y., 2002:
Phase II study of paclitaxel (Genaxol) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC)

Thongprasert, S., 1998:
Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer

Laohavinij, S.; Maoleekoonpairoj, S.; Cheirsilpa, A.; Maneechavakajorn, J.; Sirachainant, E.; Arpornvivat, W.; Jaisathaporn, K.; Ratanatharathorn, V., 1999:
Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer

Lück, H.J.; Thomssen, C.; du Bois, A.; Untch, M.; Lisboa, B.; Köhler, G.; Diergarten, K., 1997:
Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer

Boyer, M.J.; Mitchell, P.; Goldstein, D.; Millward, M.J.; Olver, I.N.; Clarke, S.J.; Richardson, G.; Davis, I., 2001:
Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer

Lissoni, A.; Zanetta, G.; Losa, G.; Gabriele, A.; Parma, G.; Mangioni, C., 1996:
Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer

Romaguera, J.E.; Rodriguez, M.A.; Hagemeister, F.B.; McLaughlin, P.; Rodriguez, J.; Preti, A.; Younes, A.; Sarris, A.H.; Cabanillas, F., 2000:
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

Rivera, E.; Holmes, F.A.; Frye, D.; Valero, V.; Theriault, R.L.; Booser, D.; Walters, R.; Buzdar, A.U.; Dhingra, K.; Fraschini, G.; Hortobagyi, G.N., 2001:
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy

Bokemeyer, C.; Beyer, J.; Metzner, B.; Ruther, U.; Harstrick, A.; Weissbach, L.; Kohrmann, U.; Verbeek, W.; Schmoll, H.J., 1996:
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer

Papamichael, D.; Gallagher, C.J.; Oliver, R.T.; Johnson, P.W.; Waxman, J., 1997:
Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter

Yamaguchi, K.; Tada, M.; Horikoshi, N.; Otani, T.; Takiuchi, H.; Saitoh, S.; Kanamaru, R.; Kasai, Y.; Koizumi, W.; Sakata, Y.; Taguchi, T., 2002:
Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer

Harrington, K.J.; Lewanski, C.; Northcote, A.D.; Whittaker, J.; Peters, A.M.; Vile, R.G.; Stewart, J.S., 2001:
Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck

Samantas, E.; Kalofonos, H.; Linardou, H.; Nicolaides, C.; Mylonakis, N.; Fountzilas, G.; Kosmidis, P.; Skarlos, D., 2001:
Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study

de Wit, R.; van der Burg, M.E.; van den Gaast, A.; Logmans, A.; Stoter, G.; Verweij, J., 1994:
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy

Kavanagh, J.J..; Tresukosol, D..; De Leon, C..Gonzalez.; Edwards, C.L..; Freedman, R.S..; Hord, M..; Howell, E..; Lenzi, R..; Krakoff, I.H..; Kudelka, A.P.., 1995:
Phase II study of prolonged oral etoposide in refractory ovarian cancer

Fulton, D.; Urtasun, R.; Forsyth, P., 1996:
Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma

de Vries, M.J.; Schilder, J.N.; Mulder, C.L.; Vrancken, A.M.; Remie, M.; Garssen, B., 1997:
Phase II study of psychotherapeutic intervention in advanced cancer

Blay, J.Y.; Judson, I.; Rodenhuis, S.; Hermans, C.; Smith, M.; van Glabbeke, M.; Verweij, J., 2000:
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens

Sato, A.; Kurihara, M.; Horikoshi, N.; Aiba, K.; Kikkawa, N.; Shirouzu, K.; Mitachi, Y.; Sakata, Y.; Wakui, A., 1999:
Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group

Walters, R.S.; Theriault, R.L.; Booser, D.J.; Esparza, L.; Hortobagyi, G.N., 1995:
Phase II study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer

Worth, L.L.; Jaffe, N.; Benjamin, R.S.; Papadopoulos, N.E.; Patel, S.; Raymond, A.K.; Jia, S.F.; Rodriguez, C.; Gano, J.; Gianan, M.A.; Kleinerman, E.S., 1998:
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma

Chen, S.C.; Lin, M.C.; Chang, J.W.; Wang, S.W.; Lee, C.H.; Tsao, T.C., 2001:
Phase II study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancer

Verweij, J.; Wanders, J.; Gil, T.; Schöffski, P.; Catimel, G.; te Velde, A.; de Mulder, P.H., 1996:
Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group

Hudis, C.; Riccio, L.; Holmes, F.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Moynahan, M.; Raptis, G.; Sklarin, N.; Surbone, A.; Uhlenhopp, M.; Maickel, N.; Yao, T.J.; Hellmann, S.; Usakewicz, J.; Hortobagyi, G.; Norton, L., 1998:
Phase II study of semisynthetic paclitaxel in metastatic breast cancer

Roelofs, E.J.; Wagener, D.J.; Conroy, T.; Wils, J.; Burghouts, J.T.; Fickers, M.; de Graeff, A.; Lalisang, F.; Paillot, B., 1993:
Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer

Takahashi, S.; Kinoshita, T.; Konishi, M.; Nakagouri, T.; Inoue, K.; Ono, M.; Sugitou, M.; Ohtsu, A.; Boku, N.; Yoshida, S., 2002:
Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer

Crump, M.; Couban, S.; Meyer, R.; Rudinskas, L.; Zanke, B.; Gluck, S.; Maksymiuk, A.; Hoskins, P.; Matthews, S.; Eisenhauer, E., 2002:
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study

Belch, A.R.; Eisenhauer, E.A.; Muldal, A.; Browman, G.; Klasa, R.; Osterwalder, B., 1995:
Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon alpha-2a in previously treated patients with multiple myeloma

Dawson, N.; Figg, W.D.; Brawley, O.W.; Bergan, R.; Cooper, M.R.; Senderowicz, A.; Headlee, D.; Steinberg, S.M.; Sutherland, M.; Patronas, N.; Sausville, E.; Linehan, W.M.; Reed, E.; Sartor, O., 1998:
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal

Chen, Y.; Perng, R.P.; Yang, K.Y.; Lin, W.C.; Wu, H.W.; Tsai, C.M.; Whang-Peng, J., 2000:
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy

Christodoulou, C.; Bafaloukos, D.; Kosmidis, P.; Samantas, E.; Bamias, A.; Papakostas, P.; Karabelis, A.; Bacoyiannis, C.; Skarlos, D.V., 2001:
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

Marx, G.M.; Pavlakis, N.; McCowatt, S.; Boyle, F.M.; Levi, J.A.; Bell, D.R.; Cook, R.; Biggs, M.; Little, N.; Wheeler, H.R., 2002 :
Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme

Clerici, M.; De Marinis, F.; Piazza, E.; Frontini, L.; Tucci, E.; Barni, S.; Bretti, S.; Luporini, G.; Intini, C., 1999:
Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer

ten Bokkel Huinink, W.W.; van Warmerdam, L.J.; Helmerhorst, T.J.; Schaefers, M.C.; Beijnen, J.H.; Rodenhuis, S., 1997:
Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer

Miller, V.A.; Ng, K.K.; Grant, S.C.; Kindler, H.; Pizzo, B.; Heelan, R.T.; von Roemeling, R.; Kris, M.G., 1998:
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer

Miller, K.D.; Picus, J.; Blanke, C.; John, W.; Clark, J.; Shulman, L.N.; Thornton, D.; Rowinsky, E.; Loehrer, P.J., 2000:
Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer

Stewart, D.J.; Eisenhauer, E.; Macdonald, D.R.; Cairncross, J.G.; Langleben, A., 1993:
Phase II study of tiazofurin in gliomas in adults. A National Cancer Institute of Canada study

Bramwell, V.H.; Eisenhauer, E.A.; Blackstein, M.; Boos, G.; Knowling, M.; Jolivet, J.; Bogues, W., 1995:
Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma

Macdonald, D.; Cairncross, G.; Stewart, D.; Forsyth, P.; Sawka, C.; Wainman, N.; Eisenhauer, E., 1996:
Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group

Giles, F.J.; Garcia-Manero, G.; Cortes, J.E.; Baker, S.D.; Miller, C.B.; O'Brien, S.M.; Thomas, D.A.; Andreeff, M.; Bivins, C.; Jolivet, J.; Kantarjian, H.M., 2002:
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia

Sekine, I.; Nishiwaki, Y.; Ogino, T.; Yokoyama, A.; Saito, M.; Mori, K.; Tsukiyama, I.; Tsuchiya, S.; Hayakawa, K.; Yoshimura, K.; Ishizuka, N.; Saijo, N., 2002:
Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306

Vermorken, J..B..; Mangioni, C..; Pecorelli, S..; Van Der Burg, M..E..L..; Van Oosterom, A..T..; Ten Bokkel Huinink, W..W..; Rotmensz, N..; Dalesio, O.., 2001:
Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix

Jassem, J.; Karnicka-Młodkowska, H.; van Pottelsberghe, C.; van Glabbeke, M.; Noseda, M.A.; Ardizzoni, A.; Gozzelino, F.; Planting, A.; van Zandwijk, N., 1993:
Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group

Isokangas, O.P.; Knuuttila, A.; Halme, M.; Mäntylä, M.; Lindström, I.; Nikkanen, V.; Viren, M.; Joensuu, H.; Mattson, K., 1999:
Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer

Furuse, K.; Kubota, K.; Kawahara, M.; Takada, M.; Kimura, I.; Fujii, M.; Ohta, M.; Hasegawa, K.; Yoshida, K.; Nakajima, S.; Ogura, T.; Niitani, H., 1996:
Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group

Oudard, S.; Caty, A.; Humblet, Y.; Beauduin, M.; Suc, E.; Piccart, M.; Rolland, F.; Fumoleau, P.; Bugat, R.; Houyau, P.; Monnier, A.; Sun, X.; Montcuquet, P.; Breza, J.; Novak, J.; Gil, T.; Chopin, D., 2001:
Phase II study of vinorelbine in patients with androgen-independent prostate cancer

Baldini, E.; Tibaldi, C.; Chella, A.; Angeletti, C.A.; Silvano, G.; Andrei, A.; Algeri, R.; Conte, P.F., 1996:
Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer

Goss, P.E.; Clark, R.M.; Ambus, U.; Weizel, H.A.; Wadden, N.A.; Crump, M.; Walde, D.; Tye, L.M.; D.C.ster, R.; Bruynseels, J., 1995:
Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen

Lorenz, M.; Mueller, H.H.; Mattes, E.; Gassel, H.J.; Junginger, T.; Saeger, H.D.; Schramm, H.; Staib-Sebler, E.; Vetter, G.; Heinrich, S.; Köhne, C.H., 2001:
Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas

Esteva, F.J.; Valero, V.; Booser, D.; Guerra, L.T.; Murray, J.L.; Pusztai, L.; Cristofanilli, M.; Arun, B.; Esmaeli, B.; Fritsche, H.A.; Sneige, N.; Smith, T.L.; Hortobagyi, G.N., 2002:
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer

Aihara, T.; Kim, Y.; Takatsuka, Y., 2002:
Phase II study of weekly docetaxel in patients with metastatic breast cancer

Beer, T.M.; Pierce, W.C.; Lowe, B.A.; Henner, W.D., 2001:
Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

van den Bent, M.J.; Pronk, L.; Sillevis Smitt, P.A.; Vecht, C.J.; Eskens, F.A.; Verweij, J., 1999:
Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma

Baselga, J.; Tripathy, D.; Mendelsohn, J.; Baughman, S.; Benz, C.C.; Dantis, L.; Sklarin, N.T.; Seidman, A.D.; Hudis, C.A.; Moore, J.; Rosen, P.P.; Twaddell, T.; Henderson, I.C.; Norton, L., 1999:
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer

Naka, N.; Kawahara, M.; Okishio, K.; Hosoe, S.; Ogawara, M.; Atagi, S.; Takemoto, Y.; Ueno, K.; Kawaguchi, T.; Tsuchiyama, T.; Furuse, K., 2002:
Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer

Aghajanian, C.; Fennelly, D.; Shapiro, F.; Waltzman, R.; Almadrones, L.; O'Flaherty, C.; O'Conner, K.; Venkatraman, E.; Barakat, R.; Curtin, J.; Brown, C.; Reich, L.; Wuest, D.; Norton, L.; Hoskins, W.; Spriggs, D.R., 1998:
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer

van den Bent, M.J.; Schellens, J.H.; Vecht, C.J.; Sillevis Smit, P.A.; Loosveld, O.J.; Ma, J.; Tijssen, C.C.; Jansen, R.L.; Kros, J.M.; Verweij, J., 1999:
Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas

Verweij, J.; de Mulder, P.H.; de Graeff, A.; Vermorken, J.B.; Wildiers, J.; Kerger, J.; Schornagel, J.; Cognetti, F.; Kirkpatrick, A.; Sahmoud, T.; Lefebvre, J.L., 1996:
Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group

Rau, B.; Wust, P.; Gellermann, J.; Tilly, W.; Hünerbein, M.; Löffel, J.; Stahl, H.; Riess, H.; Budach, V.; Felix, R.; Schlag, P., 1998:
Phase II study on preoperative radio-chemo-thermotherapy in locally advanced rectal carcinoma

van Hoesel, Q.G.; Verweij, J.; Catimel, G.; Clavel, M.; Kerbrat, P.; van Oosterom, A.T.; Kerger, J.; Tursz, T.; van Glabbeke, M.; van Pottelsberghe, C., 1994:
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group

Chen, Y.M.; Perng, R.P.; Whang-Peng, J.; Wu, H.W.; Lin, W.C.; Tsai, C.M., 2001:
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer

Villar-Grimalt, A.; Aranda, E.; Massutí, B.; Belón, J.; Antón, A.; Jimeno, J.M.; Candel, M.T.; García de Paredes, M.L.; Colajori, E., 1994:
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society)

Maoleekoonpairoj, S.; Phromratanapongse, P.; Puttanuparp, S., 1998 :
Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma

Fletcher, J.L., 2002:
Phase II temporomandibular joint disorder treatment

Kucuk, O.; Young, M.L.; Habermann, T.M.; Wolf, B.C.; Jimeno, J.; Cassileth, P.A., 2000:
Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study

Esteva, F.J.; Soh, L.T.; Holmes, F.A.; Plunkett, W.; Meyers, C.A.; Forman, A.D.; Hortobagyi, G.N., 2000:
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer

Antón, A.; Díaz-Fernández, N.; González Larriba, J.L.; Vadell, C.; Masutti, B.; Montalar, J.; Barneto, I.; Artal, A.; Rosell, R., 1999:
Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)

Hasbini, A.; Mahjoubi, R.; Fandi, A.; Chouaki, N.; Taamma, A.; Lianes, P.; Cortès-Funes, H.; Alonso, S.; Armand, J.P.; Cvitkovic, E.; Raymond, E., 1999:
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type

Hsu, C.; Huang, C-Sheng.; Chao, T-Yi.; Lu, Y-Shen.; Bu, C-Fang.; Chen, M.M.; Chang, K-Jeng.; Cheng, A-Lii., 2002:
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma

Jeanfaivre, T.; Souday, V.; Chaleil, D.; Maillet, F.; Tuchais, E., 2000:
Phase II trial evaluating the effect of megestrol acetate-prednisolone combination in the treatment of anorexia during the palliative-care phase of lung cancer

Guastalla, J.P.; Vermorken, J.B.; Wils, J.A.; George, M.; Scotto, V.; Nooij, M.; ten Bokkel Huinnink, W.W.; Dalesio, O.; Renard, J., 1994:
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group

Jiao, X.; Liu, G.Y.; Shan, C.O.; Zhao, X.; Li, X.W.; Gathmann, I.; Royce, C., 1998:
Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria

Cascinu, S.; Del Ferro, E.; Ligi, M.; Graziano, F.; Castellani, A.; Catalano, G., 1996:
Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy

Arnold, A.; Ayoub, J.; Douglas, L.; Hoogendoorn, P.; Skingley, L.; Gelmon, K.; Hirsh, V.; Eisenhauer, E., 1994:
Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

Rothenberg, M.L.; Benedetti, J.K.; Macdonald, J.S.; Seay, T.E.; Neubauer, M.A.; George, C.S.; Tanaka, M.S.; Giguere, J.K.; Pruitt, B.T.; Abbruzzese, J.L., 2002:
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study

Ravandi, F.; Rytting, M.E.; Osmon, C.; Braud, E.L.; Roach, R.W.; Edwards, K.; Winn, R.; Abbruzzese, J.L.; Pazdur, R., 2000:
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer

André, T.; Lotz, J.P.; Bouleuc, C.; Azzouzi, K.; Houry, S.; Hannoun, L.; See, J.; Esteso, A.; Avenin, D.; Izrael, V., 1996:
Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma

Pazdur, R.; Medgyesy, D.C.; Winn, R.J.; Dakhil, S.R.; Moore, D.F.; Scalzo, A.; Hoff, P.M.; Arbuck, S.G.; Abbruzzese, J.L., 1999:
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma

Whitehead, R.P.; Unger, J.M.; Flaherty, L.E.; Eckardt, J.R.; Taylor, S.A.; Didolkar, M.S.; Samlowski, W.; Sondak, V.K., 2001:
Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group study

Celik, I.; Kars, A.; Güler, N.; Barişta, I.; Tekuzman, G.; Ozyilkan, O.; Hayran, M.; Firat, D., 1998:
Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas

Khoo, K.; Brandes, L.; Reyno, L.; Arnold, A.; Dent, S.; Vandenberg, T.; Lebwohl, D.; Fisher, B.; Eisenhauer, E., 1999:
Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada clinical trials group study

Brown, K.S.; Levitt, D.J.; Shannon, M.; Link, B.K., 2002:
Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma

Pazdur, R.; Meropol, N.J.; Casper, E.S.; Fuchs, C.; Douglass, H.O.; Vincent, M.; Abbruzzese, J.L., 1996:
Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer

Tan, E.H.; Khoo, K.S.; Wee, J.; Fong, K.W.; Lee, K.S.; Lee, K.M.; Chua, E.T.; Tan, T.; Khoo-Tan, H.S.; Yang, T.L.; Au, E.; Tao, M.; Ong, Y.K.; Chua, E.J., 1999:
Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

Kris, M.G.; Clark, R.A.; Tyson, L.B.; Hahne, W.F.; Pisters, K.M.; Gralla, R.J., 1993:
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2

Mikulski, S.M.; Costanzi, J.J.; Vogelzang, N.J.; McCachren, S.; Taub, R.N.; Chun, H.; Mittelman, A.; Panella, T.; Puccio, C.; Fine, R.; Shogen, K., 2002:
Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma

Ellerhorst, J.A.; Tu, S.M.; Amato, R.J.; Finn, L.; Millikan, R.E.; Pagliaro, L.C.; Jackson, A.; Logothetis, C.J., 1998:
Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer

Louvet, C.; André, T.; Hammel, P.; Selle, F.; Landi, B.; Cattan, S.; Fonck, M.; Flesch, M.; Colin, P.; Balosso, J.; Ruszniewski, P.; de Gramont, A., 2001:
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)

Stathopoulos, G.P.; Rigatos, S.K.; Pergantas, N.; Tsavdarides, D.; Athanasiadis, I.; Malamos, N.A.; Stathopoulos, J.G., 2002:
Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer

Motzer, R.J.; Rakhit, A.; Thompson, J.; Gurney, H.; Selby, P.; Figlin, R.; Negrier, S.; Ernst, S.; Siebels, M.; Ginsberg, M.; Rittweger, K.; Hooftman, L., 2002:
Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma

Varterasian, M.L.; Mohammad, R.M.; Shurafa, M.S.; Hulburd, K.; Pemberton, P.A.; Rodriguez, D.H.; Spadoni, V.; Eilender, D.S.; Murgo, A.; Wall, N.; Dan, M.; Al-Katib, A.M., 2000:
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

Matsui, K.; Masuda, N.; Fukuoka, M.; Yana, T.; Hirashima, T.; Komiya, T.; Kobayashi, M.; Kawahara, M.; Atagi, S.; Ogawara, M.; Negoro, S.; Kudoh, S.; Furuse, K., 1998:
Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer

Quinn, J.A.; Pluda, J.; Dolan, M.Eileen.; Delaney, S.; Kaplan, R.; Rich, J.N.; Friedman, A.H.; Reardon, D.A.; Sampson, J.H.; Colvin, O.Michael.; Haglund, M.M.; Pegg, A.E.; Moschel, R.C.; McLendon, R.E.; Provenzale, J.M.; Gururangan, S.; Tourt-Uhlig, S.; Herndon, J.E.; Bigner, D.D.; Friedman, H.S., 2002:
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

Wierzbicki, R.; Ezzat, A.; Abdel-Warith, A.; Ayoub, A.; Kagevi, I.; Fadda, M.; Sieck, J.; Abdulkareem, M.; Amin, T.; Yazigi, A., 1994:
Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC)

Cure, H.; Chevalier, V.; Pezet, D.; Bousquet, J.; Focan, C.; Levi, F.; Garufi, C.; Chipponi, J.; Chollet, P., 2001:
Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer

Curé, H.; Chevalier, V.; Adenis, A.; Tubiana-Mathieu, N.; Niezgodzki, G.; Kwiatkowski, F.; Pezet, D.; Perpoint, B.; Coudert, B.; Focan, C.; Lévi, F.; Chipponi, J.; Chollet, P., 2002:
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer

Rajagopalan, K.; Peereboom, D.; Budd, G.T.; Olencki, T.; Murthy, S.; Elson, P.; McLain, D.; Bukowski, R., 1999:
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer

Hitt, R.; Castellano, D.; Hidalgo, M.; García-Carbonero, R.; Peña, M.; Brandariz, A.; Millán, J.M.; Alvarez Vincent, J.J.; Cortés-Funes, H., 1999:
Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck

Patt, Y.Z.; Hassan, M.M.; Lozano, R.D.; Waugh, K.A.; Hoque, A.M.; Frome, A.I.; Lahoti, S.; Ellis, L.; Vauthey, J.N.; Curley, S.A.; Schnirer, I.I.; Raijman, I., 2001:
Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer

Viñolas, N.; Graus, F.; Mellado, B.; Caralt, L.; Estapé, J., 1997:
Phase II trial of cisplatinum and etoposide in brain metastases of solid tumors

Nakanishi, Y.; Kawarada, Y.; Hirose, N.; Ninomiya, K.; Miyazaki, M.; Miyazaki, N.; Kurita, Y.; Kanegae, H.; Ohgushi, O.; Ogata, K.; Yamazaki, H.; Inutsuka, S.; Hara, N., 1998:
Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group

Eckel, F.; Lersch, C.; Lippl, F.; Assmann, G.; Schulte-Frohlinde, E., 2001:
Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer

Roche, H.; Cure, H.; Adenis, A.; Fargeot, P.; Terret, C.; Lentz, M.A.; Madelmont, J.C.; Fumoleau, P.; Hanausk, A.; Chollet, P., 2001:
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults

Ramanathan, R.K.; Cnaan, A.; Hahn, R.G.; Carbone, P.P.; Haller, D.G., 2001:
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282

Hendren, S.K.; Hahn, S.M.; Spitz, F.R.; Bauer, T.W.; Rubin, S.C.; Zhu, T.; Glatstein, E.; Fraker, D.L., 2001:
Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors

Pazdur, R.; Lassere, Y.; Soh, L.T.; Ajani, J.A.; Bready, B.; Soo, E.; Sugarman, S.; Patt, Y.; Abbruzzese, J.L.; Levin, B., 1994:
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma

Francis, P.A.; Rigas, J.R.; Kris, M.G.; Pisters, K.M.; Orazem, J.P.; Woolley, K.J.; Heelan, R.T., 1994:
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

Smith, R.E.; Anderson, S.J.; Brown, A.; Scholnik, A.P.; Desai, A.M.; Kardinal, C.G.; Lembersky, B.C.; Mamounas, E.P., 2003:
Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58

Buesa, J.M.; López-Pousa, A.; Martín, J.; Antón, A.; García del Muro, J.; Bellmunt, J.; Arranz, F.; Valentí, V.; Escudero, P.; Menéndez, D.; Casado, A.; Poveda, A., 1998:
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)

Foss, F.M.; Ihde, D.C.; Linnoila, I.R.; Fischmann, A.B.; Schechter, G.P.; Cotelingam, J.D.; Steinberg, S.M.; Ghosh, B.C.; Stocker, J.L.; Bastian, A., 1994:
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

Feliu, J.; López Alvarez, M.P.; Jaraiz, M.A.; Constenla, M.; Vicent, J.M.; Belón, J.; López Gómez, L.; de Castro, J.; Dorta, J.; González Barón, M., 2000:
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group

Sandler, A.B.; Kindler, H.L.; Einhorn, L.H.; Mitchell, E.; Masters, G.; Kraut, M.; Nicol, S.; Raghavan, D., 2000:
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction

Nagourney, R.A.; Brewer, C.A.; Radecki, S.; Kidder, W.A.; Sommers, B.L.; Evans, S.S.; Minor, D.R.; DiSaia, P.J., 2002:
Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients

O'Shaughnessy, J.; Vukelja, S.J.; Marsland, T.; Kimmel, G.; Ratnam, S.; Pippen, J., 2002:
Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results

Sánchez-Rovira, P.; Jaén, A.; González, E.; Porras, I.; Dueñas, M.R.; Medina, B.; Mohedano, N.; Fernández, M.; Martos, M.; Lozano, A., 2002:
Phase II trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer

Nieto, Y.; Cagnoni, P.J.; Shpall, E.J.; Matthes, S.; Barón, A.; Jones, R.B.; Bearman, S.I., 1999:
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease

Shapiro, C.L.; Ervin, T.; Welles, L.; Azarnia, N.; Keating, J.; Hayes, D.F., 1999:
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group

Goedhals, L.; Vorobiof, D.A.; Bezwoda, W.; Van Merwe, A.; Jordaan, J.P.; Barnardt, P.; Smith, B.L., 2000:
Phase II trial of i.v. vinorelbine and cisplatin in inoperable locally advanced or disseminated non-small-cell lung cancer: the South African experience

Schilder, R.J.; Goldberg, M.; Millenson, M.M.; Movsas, B.; Rogatko, A.; Rogers, B.; Langer, C.J., 2000:
Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung

Janik, J.E.; Miller, L.L.; Longo, D.L.; Powers, G.C.; Urba, W.J.; Kopp, W.C.; Gause, B.L.; Curti, B.D.; Fenton, R.G.; Oppenheim, J.J.; Conlon, K.C.; Holmlund, J.T.; Sznol, M.; Sharfman, W.H.; Steis, R.G.; Creekmore, S.P.; Alvord, W.G.; Beauchamp, A.E.; Smith, J.W., 1996:
Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma

Dutcher, J.P.; Logan, T.; Gordon, M.; Sosman, J.; Weiss, G.; Margolin, K.; Plasse, T.; Mier, J.; Lotze, M.; Clark, J.; Atkins, M., 2000:
Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study

Guastalla, J.P.; Lhomme, C.; Kerbrat, P.; Mayer, F.; Namer, M.; Goupil, P.; Charrot, P.; Heron, J.F.; Chazard, M.; Richard, I., 1994:
Phase II trial of intraperitoneal carboplatin in ovarian carcinoma patients with macroscopic residual disease at second-look laparotomy. A multicentre study of the French Fédération Nationale des Centres de Lutte Contre le Cancer

Morgan, R.J.; Braly, P.; Cecchi, G.; Leong, L.; Shibata, S.; Margolin, K.; Somlo, G.; McNamara, M.; Longmate, J.; Schinke, S.; Raschko, J.; Nagasawa, S.; Kogut, N.; Parker, P.; Stein, A.; Cho, J.; Smith, E.; Coluzzi, P.; Najera, L.; Johnson, D.; Womack, E.; Doroshow, J.H., 1999:
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up

Patt, Y.Z.; Jones, D.V.; Hoque, A.; Lozano, R.; Markowitz, A.; Raijman, I.; Lynch, P.; Charnsangavej, C., 1996:
Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer

Bodurka, D.C.; Levenback, C.; Wolf, J.K.; Gano, J.; Wharton, J.Taylor.; Kavanagh, J.J.; Gershenson, D.M., 2003:
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer

Murad, A.M..; Oliveira, M..; Saldanha, T.M.., 1994:
Phase II trial of isotretinoin and interferon alpha-2a in the treatment of advanced recurrent cervical carcinoma

Steele, J.P.; O'Doherty, C.A.; Shamash, J.; Evans, M.T.; Gower, N.H.; Tischkowitz, M.D.; Rudd, R.M., 2001:
Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma

Chidiac, T.; Budd, G.T.; Pelley, R.; Sandstrom, K.; McLain, D.; Elson, P.; Crownover, R.; Marks, K.; Muschler, G.; Joyce, M.; Zehr, R.; Bukowski, R., 2000:
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas

Eckel, F.; Lersch, C.; Assmann, G.; Schulte-Frohlinde, E., 2000:
Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer

Moore, D.F.; Brown, T.D.; LeBlanc, M.; Dahlberg, S.; Miller, T.P.; McClure, S.; Fisher, R.I., 2000:
Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trial

Malik, U.R.; Dutcher, J.P.; Caliendo, G.; Lasala, P.; Mitnick, R.; Wiernik, P.H., 1998:
Phase II trial of merbarone in patients with malignant brain tumors

Taal, B.G.; Audisio, R.A.; Bleiberg, H.; Blijham, G.H.; Neijt, J.P.; Veenhof, C.H.; Duez, N.; Sahmoud, T., 1993:
Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study

Reardon, D.A.; Akabani, G.; Coleman, R.Edward.; Friedman, A.H.; Friedman, H.S.; Herndon, J.E.; Cokgor, I.; McLendon, R.E.; Pegram, C.N.; Provenzale, J.M.; Quinn, J.A.; Rich, J.N.; Regalado, L.V.; Sampson, J.H.; Shafman, T.D.; Wikstrand, C.J.; Wong, T.Z.; Zhao, X-Guang.; Zalutsky, M.R.; Bigner, D.D., 2002:
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas

Alonso, V.; Santader, C.; Florian, J.; Alonso, M.; Isla, M.D.; Escudero, P.; Saenz, A.; Tres, A., 1996:
Phase II trial of oral tegafur and folinic acid with mitoxantrone as first-line regimen in patients with metastatic breast cancer

Degardin, M.; Cappelaere, P.; Krakowski, I.; Fargeot, P.; Cupissol, D.; Brienza, S., 1996:
Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck

Bécouarn, Y.; Ychou, M.; Ducreux, M.; Borel, C.; Bertheault-Cvitkovic, F.; Seitz, J.F.; Nasca, S.; Nguyen, T.D.; Paillot, B.; Raoul, J.L.; Duffour, J.; Fandi, A.; Dupont-André, G.; Rougier, P., 1998:
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers

Thomas, P.; Castelnau, O.; Paillotin, D.; Léna, H.; Robinet, G.; Muir, J.F.; Delaval, P.; Gouva, S.; Balmes, P.; Blanchon, F.; Perdu, D.; Poirier, R.; Pommier, D.S.nti, P.; Penot-Ragon, C.; Kleisbauer, J.P., 2001:
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study

Breathnach, O.S.; Georgiadis, M.S.; Schuler, B.S.; Pizzella, P.; Llorens, V.; Kasturi, V.; Steinberg, S.M.; O'Neil, K.; Takimoto, C.H.; Johnson, B.E., 2000:
Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer

Yamada, Y.; Shirao, K.; Ohtsu, A.; Boku, N.; Hyodo, I.; Saitoh, H.; Miyata, Y.; Taguchi, T., 2001:
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

Ratanatharathorn, V.; Lorvidhaya, V.; Maoleekoonpairoj, S.; Phromratanapongse, P.; Sirilerttrakul, S.; Kraipiboon, P.; Cheirsilpa, A.; Tangkaratt, S.; Srimuninnimit, V.; Pattaranutaporn, P., 2001:
Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

Skubitz, K.M., 2002:
Phase II trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma

Skubitz, K.M., 2002:
Phase II trial of pegylated-liposomal doxorubicin (Doxil) in renal cell cancer

Clarke, S.J.; Abratt, R.; Goedhals, L.; Boyer, M.J.; Millward, M.J.; Ackland, S.P., 2002:
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Taylor, S.A.; Benedetti, J.; Schuller, D.; Richman, S.P.; Broun, G.O.; Hantel, A., 1993:
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial

Kuratsu, J.I.; Arita, N.; Kayama, T.; Kubo, N.; Mori, T.; Sawamura, Y.; Ushio, Y., 2000:
Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients

Mehta, V.K.; Cho, C.; Ford, J.M.; Jambalos, C.; Poen, J.; Koong, A.; Lin, A.; Bastidas, J.Augusto.; Young, H.; Dunphy, E.P.; Fisher, G., 2002:
Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer

Buckner, J.C.; Gesme, D.; O'Fallon, J.R.; Hammack, J.E.; Stafford, S.; Brown, P.D.; Hawkins, R.; Scheithauer, B.W.; Erickson, B.J.; Levitt, R.; Shaw, E.G.; Jenkins, R., 2003:
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities

Berg, S.L.; Blaney, S.M.; Sullivan, J.; Bernstein, M.; Dubowy, R.; Harris, M.B., 2000:
Phase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II study

Bramhall, S.R.; Harrison, J.D.; Burton, A.; Wallace, D.M.; Chan, K.K.; Harrison, G.; White, A.; Fielding, J.W., 1999:
Phase II trial of radical surgery for locally advanced pelvic neoplasia

Buckner, J.C.; Burch, P.A.; Cascino, T.L.; O'Fallon, J.R.; Scheithauer, B.W., 1998:
Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma

Palmero, D.; Eiguchi, K.; Rendo, P.; Castro Zorrilla, L.; Abbate, E.; González Montaner, L.J., 1999:
Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up

Redman, B.G.; Hillman, G.G.; Flaherty, L.; Forman, J.; Dezso, B.; Haas, G.P., 1998:
Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma

Dillman, R.O.; Soori, G.; Wiemann, M.C.; Schulof, R.; Dobbs, T.W.; Ruben, R.H.; DePriest, C.B.; Church, C., 2001:
Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11

Dreicer, R.; Smith, D.C.; Williams, R.D.; See, W.A., 2000:
Phase II trial of suramin in patients with metastatic renal cell carcinoma

Patt, Y.Z.; Hassan, M.M.; Lozano, R.D.; Brown, T.D.; Vauthey, J.Nicolas.; Curley, S.A.; Ellis, L.M., 2003:
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

Groves, M.D.; Puduvalli, V.K.; Hess, K.R.; Jaeckle, K.A.; Peterson, P.; Yung, W.K.Alfred.; Levin, V.A., 2002:
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme

Motzer, R.J.; Berg, W.; Ginsberg, M.; Russo, P.; Vuky, J.; Yu, R.; Bacik, J.; Mazumdar, M., 2002:
Phase II trial of thalidomide for patients with advanced renal cell carcinoma

Escudier, B.; Lassau, N.; Couanet, D.; Angevin, E.; Mesrati, F.; Leborgne, S.; Garofano, A.; Leboulaire, C.; Dupouy, N.; Laplanche, A., 2002:
Phase II trial of thalidomide in renal-cell carcinoma

Judson, I.; Cerny, T.; Epelbaum, R.; Dunlop, D.; Smyth, J.; Schaefer, B.; Roelvink, M.; Kaplan, S.; Hanauske, A., 1997:
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigation

Muggia, F.M.; Blessing, J.A.; Sorosky, J.; Reid, G.C., 2002:
Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study

Bedikian, A.Y.; Legha, S.S.; Eton, O.; Buzaid, A.C.; Papadopoulos, N.; Coates, S.; Simmons, T.; Neefe, J.; von Roemeling, R., 1997:
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma

Blaney, S.M.; Needle, M.N.; Gillespie, A.; Sato, J.K.; Reaman, G.H.; Berg, S.L.; Adamson, P.C.; Krailo, M.D.; Bleyer, W.A.; Poplack, D.G.; Balis, F.M., 1998:
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study

Budd, G.Thomas.; Rankin, C.; Hutchins, L.F.; Wong, L.; Petruska, P.J.; Antman, K., 2002:
Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group

Penz, M.; Kornek, G.V.; Raderer, M.; Ulrich-Pur, H.; Fiebiger, W.; Lenauer, A.; Depisch, D.; Krauss, G.; Schneeweiss, B.; Scheithauer, W., 2001:
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

Hügli, A.; Moro, D.; Mermillod, B.; Bolla, M.; Alberto, P.; Bonnefoi, H.; Miralbell, R., 2000:
Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines

Mani, S.; Schiano, T.; Garcia, J.C.; Ansari, R.H.; Samuels, B.; Sciortino, D.F.; Tembe, S.; Shulman, K.L.; Baker, A.; Benner, S.E.; Vokes, E.E., 1999:
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma

Mani, S.; Kugler, J.W.; Sciortino, D.F.; Garcia, J.C.; Ansari, R.H.; Humerickhouse, R.; Michelassi, F.; Posner, M.C.; Shulman, K.L.; Schilsky, R.L.; List, M.; Vokes, E.E.; Benner, S., 1998:
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study

Conroy, T.; Etienne, P.L.; Adenis, A.; Wagener, D.J.; Paillot, B.; François, E.; Bedenne, L.; Jacob, J.H.; Seitz, J.F.; Bleiberg, H.; Van Pottelsberghe, C.; Van Glabbeke, M.; Delgado, F.M.; Merle, S.; Wils, J., 1996:
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group

Choy, H.; Safran, H.; Akerley, W.; Graziano, S.L.; Bogart, J.A.; Cole, B.F., 1998:
Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer

Vaughn, D.J.; Broome, C.M.; Hussain, M.; Gutheil, J.C.; Markowitz, A.B., 2002:
Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer

Markman, M.; Hall, J.; Spitz, D.; Weiner, S.; Carson, L.; Van Le, L.; Baker, M., 2002:
Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer

Jahanzeb, M.; Mortimer, J.E.; Yunus, F.; Irwin, D.H.; Speyer, J.; Koletsky, A.J.; Klein, P.; Sabir, T.; Kronish, L., 2002:
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer

Knox, S.J.; Goris, M.L.; Tempero, M.; Weiden, P.L.; Gentner, L.; Breitz, H.; Adams, G.P.; Axworthy, D.; Gaffigan, S.; Bryan, K.; Fisher, D.R.; Colcher, D.; Horak, I.D.; Weiner, L.M., 2000:
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer

Markman, M.; DeMarco, L.C.; Birkhofer, M.; Budman, D.; Hakes, T.; Reichman, B.; Rubin, S.; Jones, W.; Barakat, R.; Curtin, J., 1993:
Phase II trial of zeniplatin (CL 286,558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy

Rebattu, P.; Coudert, B.; Schneider, M.; Ouabdesselam, R.; Lentz, M.; Hanauske, A.; Chevallierdagger, B.; Fumoleau, P.; Chollet, P., 2000:
Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma

Wils, J.A.; Kok, T.; Wagener, D.J.; Francois, E.; Selleslags, J.; Duez, N., 1993:
Phase II trial with ifosfamide in pancreatic cancer

Richardet, E.; Carranza, L.; Uribe, A.; Tolocka, H.; Cresta, C.; Uribe, E.; Uribe, M., 1995:
Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma

Sardi, J.E., 1996:
Phase II trial with neoadjuvant chemotherapy

Shelley, J.H., 1999:
Phase II trials in drug development

Anonymous, 1997:
Phase II trials in the EORTC. The Protocol Review Committee, the Data Center, the Research and Treatment Division, and the New Drug Development Office. European Organization for Research and Treatment of Cancer

Kaye, S.B.; Piccart, M.; Aapro, M.; Francis, P.; Kavanagh, J., 1998:
Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview

Kraut, E.H., 2000:
Phase II trials of pentostatin (Nipent) in hairy cell leukemia

Smith, M.A.; Anderson, B., 2001:
Phase II window studies: 10 years of experience and counting

Pantely, G.A.; Joyce, M.; Grauer, S.E.; Giraud, G.D.; Shiota, T.; Sahn, D., 1998:
Phase II, placebo-controlled trial of MRX115 (Aerosomes) for left heart and myocardial perfusion imaging

Kabbinavar, F.; Hurwitz, H.I.; Fehrenbacher, L.; Meropol, N.J.; Novotny, W.F.; Lieberman, G.; Griffing, S.; Bergsland, E., 2002:
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

Krown, S.E.; Aeppli, D.; Balfour, H.H., 1999:
Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team

Coughlin, C.; Scott, C.; Langer, C.; Coia, L.; Curran, W.; Rubin, P., 2000:
Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients

Anonymous, 1996:
Phase II/III Trials of Viracept start

Goorin, A.M.; Harris, M.B.; Bernstein, M.; Ferguson, W.; Devidas, M.; Siegal, G.P.; Gebhardt, M.C.; Schwartz, C.L.; Link, M.; Grier, H.E., 2002:
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial

Werner-Wasik, M.; Axelrod, R.S.; Friedland, D.P.; Hauck, W.; Rose, L.J.; Chapman, A.E.; Grubbs, S.; Deshields, M.; Curran, W.J., 2002:
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy

Anonymous, 1999:
Phase III CCRE option

Anonymous, 2001:
Phase III Peg-Intron plus Rebetol results released

Xu, B.; Zhou, J.; Zhou, A., 2000:
Phase III clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by cisplatin

Zhou, J.; Xu, B.; Zhou, A., 2000:
Phase III clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by non-cisplatin chemotherapy

Li, Q.; Feng, F-yi.; Han, J.; Sui, G-jie.; Zhu, Y-guang.; Zhang, Y.; Zhang, Z-hua.; Li, L.; Wang, P-hui.; Zhou, M-zhen.; Zhang, Y-chao., 2003:
Phase III clinical study of a new anticancer drug atofluding

Poirier, V.C.; Newberry, P.D.; Hecht, S.T.; Nemzek, W.R., 1996:
Phase III clinical trial comparing iodixanol and iohexol in cerebral angiography

Kimura, S.; Shimada, K.; Matsuda, J.; Gohchi, K.; Fukutake, K.; Fukue, H.; Okubo, T.; Ishigatsubo, Y.; Yamada, K.; Koitabashi, Y., 1994:
Phase III clinical trial of KRN8601 (rhG-CSF) for neutropenia in patients with human immunodeficiency virus infection

Luetje, C.M.; Brackman, D.; Balkany, T.J.; Maw, J.; Baker, R.Stanley.; Kelsall, D.; Backous, D.; Miyamoto, R.; Parisier, S.; Arts, A., 2002:
Phase III clinical trial results with the Vibrant Soundbridge implantable middle ear hearing device: a prospective controlled multicenter study

Morere, J.F., 2002:
Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001

Zinzani, P.L.; Martelli, M.; Storti, S.; Musso, M.; Cantonetti, M.; Leone, G.; Cajozzo, A.; Papa, G.; Iannitto, E.; Perrotti, A., 1995:
Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-Hodgkin's lymphoma

Mochiki, H.; Yamamoto, O.; Mizumoto, A.; Ito, S., 1995:
Phase III contraction inhibition and gastric acidification in Pavlov and Heidenhain pouch in dogs

Muggia, F.; Hamilton, A., 2001:
Phase III data on Caelyx in ovarian cancer

Zimniak, P.; Awasthi, S.; Awasthi, Y.C., 1993:
Phase III detoxification system

Vore, M., 1994:
Phase III elimination: another two-edge sword

Loprinzi, C.L.; Sloan, J.A.; Perez, E.A.; Quella, S.K.; Stella, P.J.; Mailliard, J.A.; Halyard, M.Y.; Pruthi, S.; Novotny, P.J.; Rummans, T.A., 2002:
Phase III evaluation of fluoxetine for treatment of hot flashes

Burch, P.A.; Block, M.; Schroeder, G.; Kugler, J.W.; Sargent, D.J.; Braich, T.A.; Mailliard, J.A.; Michalak, J.C.; Hatfield, A.K.; Wright, K.; Kuross, S.A., 2000:
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study

Anonymous, 2001:
Phase III hepatitis C program begins

Fort, D.J.; Stover, E.L.; Bantle, J.A.; Rayburn, J.R.; Hull, M.A.; Finch, R.A.; Burton, D.T.; Turley, S.D.; Dawson, D.A.; Linder, G.; Buchwalter, D.; Dumont, J.N.; Kumsher-King, M.; Gaudet-Hull, A.M., 1998:
Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX)

Lepor, H., 1998:
Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group

Grayburn, P.A.; Weiss, J.L.; Hack, T.C.; Klodas, E.; Raichlen, J.S.; Vannan, M.A.; Klein, A.L.; Kitzman, D.W.; Chrysant, S.G.; Cohen, J.L.; Abrahamson, D.; Foster, E.; Perez, J.E.; Aurigemma, G.P.; Panza, J.A.; Picard, M.H.; Byrd, B.F.; Segar, D.S.; Jacobson, S.A.; Sahn, D.J.; DeMaria, A.N., 1998:
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms

Feurle, G.E.; Pfeiffer, A.; Schmidt, T.; Dominguez-Munoz, E.; Malfertheiner, P.; Hamscher, G., 2001:
Phase III of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin

Rosell, R.; Gatzemeier, U.; Betticher, D.C.; Keppler, U.; Macha, H.N.; Pirker, R.; Berthet, P.; Breau, J.L.; Lianes, P.; Nicholson, M.; Ardizzoni, A.; Chemaissani, A.; Bogaerts, J.; Gallant, G., 2002:
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

André, M.; Baudoux, E.; Bron, D.; Canon, J-Luc.; D'Hondt, Véronique.; Fassotte, M-France.; D'Hondt, L.; Fillet, G.; Humblet, Y.; Jerusalem, G.; Vermeulen, P.; Symann, M.; Beguin, Y., 2003:
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies

Levin, V.A.; Uhm, J.H.; Jaeckle, K.A.; Choucair, A.; Flynn, P.J.; Yung WKA.P.ados, M.D.; Bruner, J.M.; Chang, S.M.; Kyritsis, A.P.; Gleason, M.J.; Hess, K.R., 2000:
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme

Sculier, J.P.; Paesmans, M.; Thiriaux, J.; Lecomte, J.; Bureau, G.; Giner, V.; Efremidis, A.; Lafitte, J.J.; Berchier, M.C.; Alexopoulos, C.G.; Zacharias, C.; Mommen, P.; Ninane, V.; Klastersky, J., 1998:
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party

Scagliotti, G.V.; D.M.rinis, F.; Rinaldi, M.; Crinò, L.; Gridelli, C.; Ricci, S.; Matano, E.; Boni, C.; Marangolo, M.; Failla, G.; Altavilla, G.; Adamo, V.; Ceribelli, A.; Clerici, M.; D.C.stanzo, F.; Frontini, L.; Tonato, M., 2002:
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer

Vikram, B., 2001:
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

Pass, H.I.; Temeck, B.K.; Kranda, K.; Thomas, G.; Russo, A.; Smith, P.; Friauf, W.; Steinberg, S.M., 1998:
Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma

Anonymous, 1998:
Phase III results of second-generation HIV protease inhibitor reported

Anonymous, 2001:
Phase III results presented on amprenavir triple combination

Anonymous, 1995:
Phase III saquinavir clinical trials

Johnstone, D.W.; Byhardt, R.W.; Ettinger, D.; Scott, C.B., 2002:
Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group

Takada, M.; Fukuoka, M.; Kawahara, M.; Sugiura, T.; Yokoyama, A.; Yokota, S.; Nishiwaki, Y.; Watanabe, K.; Noda, K.; Tamura, T.; Fukuda, H.; Saijo, N., 2002:
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104

Renard, A.; Noël, G.; Mazeron, J.J., 2000:
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesin and cisplatin in unresectable stage III non small-cell lung cancer

Berlin, J.D.; Catalano, P.; Thomas, J.P.; Kugler, J.W.; Haller, D.G.; Benson, A.Bowen., 2002:
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297

Shimizu, Y., 2002:
Phase III study of gynecologic cancer in Japan

Furuse, K.; Fukuoka, M.; Nishiwaki, Y.; Kurita, Y.; Watanabe, K.; Noda, K.; Ariyoshi, Y.; Tamura, T.; Saijo, N., 1998:
Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group

Emami, B.; Scott, C.; Perez, C.A.; Asbell, S.; Swift, P.; Grigsby, P.; Montesano, A.; Rubin, P.; Curran, W.; Delrowe, J.; Arastu, H.; Fu, K.; Moros, E., 1996:
Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group

Socinski, M.A.; Schell, M.J.; Peterman, A.; Bakri, K.; Yates, S.; Gitten, R.; Unger, P.; Lee, J.; Lee, J-Hyun.; Tynan, M.; Moore, M.; Kies, M.S., 2002:
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer

Nabholtz, J-Marc.; Cantin, J.; Chang, J.; Guevin, R.; Patel, R.; Tkaczuk, K.; Vodvarka, P.; Lindsay, M-Ann.; Reese, D.; Riva, A.; Mackey, J., 2002:
Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial

Pearcey, R.; Brundage, M.; Drouin, P.; Jeffrey, J.; Johnston, D.; Lukka, H.; MacLean, G.; Souhami, L.; Stuart, G.; Tu, D., 2002 :
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix

Anonymous, 2001:
Phase III trial in hepatitis B prevention

Anonymous, 2000:
Phase III trial of IL-2

Gibson, A.D., 2002:
Phase III trial of a humanized anti-CD33 antibody (HuM195) in patients with relapsed or refractory acute myeloid leukemia

Matveeva, A.G.; Nekrasov, V.M.; Maryasov, A.G., 2017:
Analytical solution of the PELDOR inverse problem using the integral Mellin transform

Estaban, E.; Lacave, A.J.; Fernández, J.L.; Corral, N.; Buesa, J.M.; Estrada, E.; Palacio, I.; Vieitez, J.M.; Muñiz, I.; Alvarez, E., 2000:
Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

Falkson, C.I.; Ibrahim, J.; Kirkwood, J.M.; Coates, A.S.; Atkins, M.B.; Blum, R.H., 1998:
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study

Siefker-Radtke, A.O.; Millikan, R.E.; Tu, S-Ming.; Moore, D.F.; Smith, T.L.; Williams, D.; Logothetis, C.J., 2002:
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer

Schrijvers, D.; Johnson, J.; Jiminez, U.; Gore, M.; Kosmidis, P.; Szpirglas, H.; Robbins, K.; Oliveira, J.; Lewensohn, R.; Schüller, J.; Riviere, A.; Arvay, C.; Langecker, P.; Jacob, H.; Cvitkovic, E.; Vokes, E., 1998:
Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group

Anonymous, 1999:
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03

MacVicar, D.; Jacobsen, T.F.; Guy, R.; Husband, J.E., 1993:
Phase III trial of oral magnetic particles in MRI of abdomen and pelvis

Anonymous, 2001:
Phase III trials for new PI

Richieri, S., 1995:
Phase III trials for whole inactivated HIV

Gams, R., 1997:
Phase III trials of toremifene vs tamoxifen

Bodsworth, N.J.; Bloch, M.; Bower, M.; Donnell, D.; Yocum, R., 2001:
Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma

Dunn, B.K.; Kramer, B.S.; Ford, L.G., 1999:
Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experience

Murray, J.J.; Solomon, E.; McCluskey, D.; Zhang, J.; Palmer, R.; Notario, G., 2001:
Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis

Adler, J.L.; Jannetti, W.; Schneider, D.; Zhang, J.; Palmer, R.; Notario, G., 2001:
Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis

Greco, A.; Parker, J.R.; Ratcliffe, C.G.; Kirchin, M.A.; McNamara, M.T., 2002:
Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions

Arimori, S.; Terada, H.; Hayami, K.; Aoyagi, Y.; Motomura, S.; Fukawa, H.; Akatsuka, N.; Shimizu, S.; Kodama, F.; Chiba, S., 1993:
Phase IV group study of natural human interferon alpha (HLBI) on chronic myelogeneous leukaemia

Segura, A.; Villalbí, J.R., 1996:
Phase IV of epidemiological studies: conceptual and methodological criticisms

Li, J.T.; Yoshida, M.; Nakatsuka, K., 1995:
Phase IV study (postmarketing surveillance) of Tarivid (ofloxacin) in China

Anonymous, 1996:
Phase Ia trial of a polynucleotide anti-tumor immunization to human carcinoembryonic antigen in patients with metastatic colorectal cancer. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama

Brooks, D.; Taylor, C.; Dos Santos, B.; Linden, H.; Houghton, A.; Hecht, T.T.; Kornfeld, S.; Taetle, R., 1995:
Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6

Grant, S.; Roberts, J.; Poplin, E.; Tombes, M.B.; Kyle, B.; Welch, D.; Carr, M.; Bear, H.D., 1998:
Phase Ib trial of bryostatin 1 in patients with refractory malignancies

Cui; Zhang; Chen, 2000:
Phase Lag and Coherence Function of X-Ray Emission from Black Hole Candidate XTE J1550-564

Friedrich; Trost, 1996:
Phase Loss in WKB Waves Due to Reflection by a Potential

Lacasta; Sancho; Sagués, 1995:
Phase Separation Dynamics under Stirring

Müller-Buschbaum; O'Neill; Affrossman; Stamm, 1998:
Phase Separation and Dewetting of Weakly Incompatible Polymer Blend Films

Cho; Chou; Johnston, 1993:
Phase Separation and Finite Size Scaling in La2-xSrxCuO4+ delta

Kumar; Weinhold, 1996:
Phase Separation in Nearly Symmetric Polymer Mixtures

van Dongen PG, 1995:
Phase Separation in the Extended Hubbard Model at Weak Coupling

Tuinier; de Kruif CG, 1999:
Phase Separation, Creaming, and Network Formation of Oil-in-Water Emulsions Induced by an Exocellular Polysaccharide

Sheng; Chen; Weng, 1996:
Phase String Effect in a Doped Antiferromagnet

So; Park; Kim; Moon, 1997:
Phase Transformation Behavior at Low Temperature in Hydrothermal Treatment of Stable and Unstable Titania Sol

Fainerman; Miller, 2000:
Phase Transition Processes in Surfactant Adsorption Layers

Ueda; Yoshikawa, 1996:
Phase Transition and Phase Segregation in a Single Double-Stranded DNA Molecule

Robinson; Drysdale, 1996:
Phase Transition between Coherent and Incoherent Three-Wave Interactions

Collins; Dhathathreyan; Ramasami, 1998:
Phase Transition in Langmuir Films of Octadecylmalonic Acid

Hill; Zia; Schmittmann, 1996:
Phase Transitions in Driven Bilayer Systems: A Monte Carlo Study

Heiselberg; Hjorth-Jensen, 1999:
Phase Transitions in Neutron Stars and Maximum Masses

Martín-Delgado; Shankar; Sierra, 1996:
Phase Transitions in Staggered Spin Ladders

Martin, S.T., 2002:
Phase Transitions of Aqueous Atmospheric Particles

Cao, P.; Luo, J.; Zhu, T., 2003:
Phase aberration correction for ultrasound imaging

Ries, L.L.; Smith, S.W., 1995:
Phase aberration correction in two dimensions using a deformable array transducer

Debbins, J.P.; Felmlee, J.P.; Riederer, S.J., 1997:
Phase alignment of multiple surface coil data for reduced bandwidth and reconstruction requirements

Van Isacker, P.F.ank; Dukelsky, 1985:
Phase ambiguities in the O(6) limit of the interacting boson model

Turnipseed, D.L., 2000:
Phase analysis of burnout and other psychological phenomena

Smith, 1985:
Phase analysis of image states and surface states associated with nearly-free-electron band gaps

Ginter, J.; Blinowska, K.J.; Kamiński, M.; Durka, P.J., 2001:
Phase and amplitude analysis in time-frequency space--application to voluntary finger movement

Ciuchi; San Miguel, M.A.raham; de Pasquale F, 1991:
Phase and amplitude correlations induced by the switch-on chirp of a detuned laser

Zeghlache; Mandel; Abraham; Weiss, 1988:
Phase and amplitude dynamics in the laser Lorenz model

Bestehorn, 1993:
Phase and amplitude instabilities for Bénard-Marangoni convection in fluid layers with large aspect ratio

Wu; Griffin, 1995:
Phase and amplitude modes in a superconductor with interlayer pair tunneling

Launois; Moussa; Lemée-Cailleau; Cailleau, 1989:
Phase and amplitude modes of the n=4 incommensurate phase II of biphenyl: Neutron scattering experiments and theoretical results

Nicolás, J.; Campos, J.; Yzuel, Mía.J., 2002:
Phase and amplitude modulation of elliptic polarization states by nonabsorbing anisotropic elements: application to liquid-crystal devices

Widmann; Sugai; Yamazaki; Hayano; Iwasaki; Nakamura; Tamura; Ito; Kawachi; Nishida; Higemoto; Ito; Morita; Hartmann; Daniel; von Egidy, T.S.hmid; Hoffmann; Eades, 1995:
Phase and density dependence of the delayed annihilation of metastable antiprotonic helium atoms in gas, liquid, and solid helium

Kesar, A.; Jerby, E., 2002:
Phase and gain measurements in a distributed-loss cyclotron-resonance maser amplifier

Padilla, F.; Laugier, P., 2000:
Phase and group velocities of fast and slow compressional waves in trabecular bone

Braunstein; Caves, 1990:
Phase and homodyne statistics of generalized squeezed states

Blank; Shapiro, 1995:
Phase and intensity control of integral and differential above-threshold ionization rates

Huang, 1994:
Phase and photon-number squeezings in a many-cascade two-photon correlated-spontaneous-emission laser

Conti, M., 2002:
Phase and solute fields across the solid-liquid interface of a binary alloy

Meng; Chai; Zhang, 1993:
Phase and squeezing properties of two copropagating fields in a Kerr medium

Dzakula, 2000:
Phase angle measurement from peak areas (PAMPAS)

Chumlea, W.C.; Guo, S.S.; Siervogel, R.M., 1998:
Phase angle spectrum analysis and body water

Ning; Haken, 1991:
Phase anholonomy in dissipative optical systems with periodic oscillations

Littlejohn, 1988:
Phase anholonomy in the classical adiabatic motion of charged particles

Brasunas, J.C., 2002:
Phase anomalies in fourier-transform spectrometers: an absorbing beam splitter is neither sufficient nor necessary

Fried; Gabellini, 1995:
Phase averaging and generalized eikonal representations

Jamee; Pitsi; Li; Nguyen; Sigaud; Thoen, 2000:
Phase behavior and blue-phase-III-isotropic critical point in (R)-(S) mixtures of a chiral liquid crystal with a direct twist-grain-boundary to blue-phase transition

Bates, M.A., 2002:
Phase behavior and free interfaces of a lattice-gas nematic-liquid-crystal model

Schwarz; Safran, 2000:
Phase behavior and material properties of hollow nanoparticles

Wilding, N.B.; Magee, J.E., 2002:
Phase behavior and thermodynamic anomalies of core-softened fluids

Knoll, A.; Horvat, A.; Lyakhova, K.S.; Krausch, G.; Sevink, G.J.A.; Zvelindovsky, A.V.; Magerle, R., 2002:
Phase behavior in thin films of cylinder-forming block copolymers

van Der Kooij FM.V.gel; Lekkerkerker, 2000:
Phase behavior of a mixture of platelike colloids and nonadsorbing polymer

Ilett; Orrock; Poon; Pusey, 1995:
Phase behavior of a model colloid-polymer mixture

Sear, 2000:
Phase behavior of a model of colloidal particles with a fluctuating internal state

Klapp, S.; Forstmann, F., 2002:
Phase behavior of aligned dipolar hard spheres: integral equations and density functional results

Lu, Q.; Zografi, G., 1998:
Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP

Velasco, E.; Navascués, G.; Mederos, L., 2002:
Phase behavior of binary hard-sphere mixtures from perturbation theory

Brunner, M.; Bechinger, C., 2002:
Phase behavior of colloidal molecular crystals on triangular light lattices

Harreis, H.M.; Kornyshev, A.A.; Likos, C.N.; Löwen, H.; Sutmann, G., 2002:
Phase behavior of columnar DNA assemblies

D.B.asio A.C.metti; Codastefano; Tartaglia; Rouch; Chen, 1993:
Phase behavior of dense three-component ionic microemulsions and electrical conductivity in the lamellar phase

Veerman; Frenkel, 1992:
Phase behavior of disklike hard-core mesogens

Dijkstra, M., 2002:
Phase behavior of hard spheres with a short-range Yukawa attraction

Bates; Frenkel, 2000:
Phase behavior of model mixtures of colloidal disks and polymers

Zhang; Laradji; Guo; Mouritsen; Zuckermann, 1992:
Phase behavior of pure lipid bilayers with mismatch interactions

Rosenbaum; Zamora; Zukoski, 1996:
Phase behavior of small attractive colloidal particles

Huang; Gibbs; Zehner; Sandy; Mochrie, 1990:
Phase behavior of the Au(111) surface: Discommensurations and kinks

Al-Bawab, A.; Friberg, S.E., 2002:
Phase behavior of the alpha-hydroxyoctanoic acid/Laureth 4/white oil/water system and preliminary evaluation of the phase changes during evaporation of its emulsion

Bellini; Clark; Muzny; Wu; Garland; Schaefer; Oliver, 1992:
Phase behavior of the liquid crystal 8CB in a silica aerogel

Qiu, H.; Caffrey, M., 2000:
Phase behavior of the monoerucin/water system

Wu, J.; Zhou, B.; Hu, Z., 2003:
Phase behavior of thermally responsive microgel colloids

Bechinger, C.; Brunner, M.; Leiderer, P., 2001:
Phase behavior of two-dimensional colloidal systems in the presence of periodic light fields

Palakodaty, S.; York, P., 1999:
Phase behavioral effects on particle formation processes using supercritical fluids

Ecke; Shu; Sullivan; Vilches, 1985:
Phase boundaries and critical and tricritical properties of monolayer 4He adsorbed on graphite

Chui, 1994:
Phase boundaries in ultrathin magnetic films

Fisher; Barbosa, 1991:
Phase boundaries near critical end points. I. Thermodynamics and universality

Barbosa; Fisher, 1991:
Phase boundaries near critical end points. II. General spherical models

Barbosa, 1992:
Phase boundaries near critical end points. III. Corrections to scaling and spherical models

Fujita; Okawa; Matsumoto; Tanaka, 1996:
Phase boundaries of nanometer scale c(2 x 2)-O domains on the Cu(100) surface

Montambaux; Naughton; Chamberlin; Yan; Chaikin; Azbel, 1989:
Phase boundary and magnetization in field-induced spin-density-wave systems

Hu; Huang, 1991:
Phase boundary of a cubic superconducting circuit in a magnetic field of arbitrary magnitude and direction

Yi; Hu, 1992:
Phase boundary of several multicube superconducting circuits in a magnetic field of arbitrary magnitude and direction

Chi; Santhanam; Blöchl, 1990:
Phase boundary of superconducting networks: A new approximation scheme

Rottman, 1990:
Phase boundary of the two-dimensional Ising model with ferromagnetic and antiferromagnetic interactions in a magnetic field

Marcus; Westervelt; Hopkins; Gossard, 1993:
Phase breaking in ballistic quantum dots: Experiment and analysis based on chaotic scattering

Bird; Ishibashi; Ferry; Ochiai; Aoyagi; Sugano, 1995:
Phase breaking in ballistic quantum dots: Transition from two- to zero-dimensional behavior

Moon, S.Joon.; Shattuck, M.D.; Bizon, C.; Goldman, D.I.; Swift, J.B.; Swinney, H.L., 2002:
Phase bubbles and spatiotemporal chaos in granular patterns

Aharonov; Anandan, 1987:
Phase change during a cyclic quantum evolution

Batten, S.R.; Harris, A.R.; Murray, K.S., 2000:
Phase change in tetraphenylphosphonium perchlorate

Wu, J.; Takeda, T.; Toyama, H.; Ajisaka, R.; Masuoka, T.; Watanabe, S.; Sato, M.; Ishikawa, N.; Itai, Y., 1999:
Phase changes caused by hyperventilation stress in spastic angina pectoris analyzed by first-pass radionuclide ventriculography

Liu, Z.; Lai, Y.C.; Hoppensteadt, F.C., 2001:
Phase clustering and transition to phase synchronization in a large number of coupled nonlinear oscillators

Hannon, J.B.; zu Heringdorf, F.J.; Tersoff, J.; Tromp, R.M., 2001:
Phase coexistence during surface phase transitions

Knott, M.; Ford, I.J., 2001:
Phase coexistence in colloidal suspensions: an analytic Poisson-Boltzmann treatment

Moretto; Phair; Ghetti; Tso; Colonna; Skulski; Wozniak; Bowman; Carlin; Chartier; Gelbke; Gong; Hsi; Kim; Lisa; Lynch; Peaslee; Schwarz; de Souza RT.T.ang; Zhu, 1996:
Phase coexistence in multifragmentation?

Stevens; Grest, 1995:
Phase coexistence of a Stockmayer fluid in an applied field

Rathe; Scully, 1995:
Phase coherence and decoherence in the correlated-spontaneous-emission laser

Kayanuma, 1993:
Phase coherence and nonadiabatic transition at a level crossing in a periodically driven two-level system

Mon; Teitel, 1989:
Phase coherence and nonequilibrium behavior in Josephson junction arrays

Brewer, 1986:
Phase coherence and quantized circulation transitions in superfluid helium

Liu; Giordano, 1990:
Phase coherence and the effect of an ac electric field on the conductance of a disordered one-dimensional system

Gould; Sachrajda; Feng; Delage; Kelly; Leung; Coleridge, 1995:
Phase coherence and trajectory trapping around one or two independently controllable antidots in quantum wires

Schmitteckert; Eckern, 1996:
Phase coherence in a random one-dimensional system of interacting fermions: A density-matrix renormalization-group study

Courtois; Gandit; Pannetier, 1995:
Phase coherence in a two-dimensional array of normal and superconducting wires

Liu; Wu; Tsong, 1992:
Phase coherence in atomic vibration in field dissociation of field desorbed diatomic ions

Miller; Gunaratne; Zou; Davis; Rampersad; Wolfe, 1994:
Phase coherence in the hysteretic magnetic behavior of parallel Josephson-junction arrays

Sásik; Stroud; Tesanovic, 1995:
Phase coherence in two-dimensional type-II superconductors

Zailer; Frost; Ford; Pepper; Simmons; Ritchie; Nicholls; Jones, 1994:
Phase coherence, interference, and conductance quantization in a confined two-dimensional hole gas

Baer, R.; Neuhauser, D., 2002:
Phase coherent electronics: a molecular switch based on quantum interference

Schumacher, H.W.; Chappert, C.; Crozat, P.; Sousa, R.C.; Freitas, P.P.; Miltat, J.; Fassbender, J.; Hillebrands, B., 2003:
Phase coherent precessional magnetization reversal in microscopic spin valve elements

Reichert; Niering; Holzwarth; Weitz; Udem; Hansch, 2000:
Phase coherent vacuum-ultraviolet to radio frequency comparison with a mode-locked laser

Kovesi, P., 2001:
Phase congruency: a low-level image invariant

Lera; Nieto-Vesperinas, 1990:
Phase conjugation by four-wave mixing of statistical beams

Saxena; Agarwal, 1985:
Phase conjugation by nondegenerate four-wave mixing with excited-state Zeeman coherences

Sawley, 1988:
Phase conjugation in a moderately dense liquid suspension of microspheres

Freysz; Laffon; Delville; Ducasse, 1994:
Phase conjugation in critical microemulsions

Rogovin, 1985:
Phase conjugation in liquid suspensions of microellipsoids in the diffusive limit

Rogovin; Sari, 1985:
Phase conjugation in liquid suspensions of microspheres in the diffusive limit

Maki; Davis; Boyd; Sipe, 1992:
Phase conjugation using the surface nonlinearity of a dense potassium vapor

Belic, 1988:
Phase conjugation via multiple gratings in photorefractive crystals

Su, 1995:
Phase considerations in the Thomas-WKB theory: Film structures, quantum wells, and quantum wires

You; Axe; Kan; Hashimoto; Moss; Liu; Crabtree; Lam, 1988:
Phase constitution and thermal expansion of YBa2Cu3O7- delta single crystals

Jones, R.; Pereira, J.; Santoreneos, S.; Vonau, M., 1999:
Phase contrast MRI assessment of thoraco-lumbar spinal cord motion in spinal dysraphism

Markl, M.; Hennig, J., 2001:
Phase contrast MRI with improved temporal resolution by view sharing: k-space related velocity mapping properties

Naidich, T.P.; Altman, N.R.; Gonzalez-Arias, S.M., 1993:
Phase contrast cine magnetic resonance imaging: normal cerebrospinal fluid oscillation and applications to hydrocephalus

Batra, S.; Sen, R.; Jain, K.; Gulati, N., 1995:
Phase contrast microscopic evaluation of placental pathology in premature gestation

Shahi, S.K.; Ranga, S.; Khurana, S.K.; Talib, V.H., 2000:
Phase contrast microscopy: utility in obstetrics and gynaecology

D.G.aef M.N.hfer; McCartney, 1999:
Phase contrast of spherical magnetic particles

Sheehy; Walker; DiMauro, 1995:
Phase control in the two-color photodissociation of HD+

Zuo; Bandrauk, 1996:
Phase control of molecular ionization: H2 + and H3 2+ in intense two-color laser fields

Gong, J.; Brumer, P., 2002:
Phase control of nonadiabaticity-induced quantum chaos in an optical lattice

Petrosyan; Lambropoulos, 2000:
Phase control of photoabsorption in optically dense media

Kaminski; Ehlotzky, 1994:
Phase control of scattering resonances in intense bichromatic laser fields

Gerkema, M.P.; Daan, S.; Wilbrink, M.; Hop, M.W.; van der Leest, F., 1993:
Phase control of ultradian feeding rhythms in the common vole (Microtus arvalis): the roles of light and the circadian system

Petrashov; Antonov; Delsing; Claeson, 1995:
Phase controlled conductance of mesoscopic structures with superconducting "mirrors"

Vining, B.A.; Bossio, R.E.; Marshall, A.G., 1999:
Phase correction for collision model analysis and enhanced resolving power of fourier transform ion cyclotron resonance mass spectra

Repp, B.H., 2001:
Phase correction, phase resetting, and phase shifts after subliminal timing perturbations in sensorimotor synchronization

Schalow, G., 1993:
Phase correlated adequate afferent action potentials as a drive of human spinal oscillators

Björk; Yamamoto, 1988:
Phase correlation in nondegenerate parametric oscillators and amplifiers: Theory and applications

Yevstafiev, V.V., 2001:
Phase density method: a microscopic description of the gas of neutral particles

Protopapas; Knight; Burnett, 1994:
Phase dependence in two-color excitation of a model atom by intense fields

Véniard; Taïeb; Maquet, 1996:
Phase dependence of (N+1)-color (N>1) ir-uv photoionization of atoms with higher harmonics

Schumacher; Weihe; Muller; Bucksbaum, 1994:
Phase dependence of intense field ionization: A study using two colors

Schumacher; Bucksbaum, 1996:
Phase dependence of intense-field ionization

Takahashi; Kawamukai, 2000:
Phase detection of electrostatic force by AFM with a conductive tip

Wang, C.M.; Chao, C.H.; Chang, S.L., 2001:
Phase determination and extension using X-ray multiple diffraction and the maximum-entropy method

Koganezawa, T.; Yoshimura, Y.; Nakamura, N.; Iwasaki, H., 2001:
Phase determination by wavelength-modulated diffraction. I. Centrosymmetric case

Clinton, 1993:
Phase determination in x-ray and neutron reflectivity using logarithmic dispersion relations

Schmidt; Colella, 1985:
Phase determination of forbidden x-ray reflections in V3Si by virtual Bragg scattering

Roach, J.; Retailleau, P.; Carter, C.W., 2001:
Phase determination via Sayre-type equations with anomalous-scattering data

Voit, 1992:
Phase diagram and correlation functions of the half-filled extended Hubbard model in one dimension

Dünweg; Landau, 1993:
Phase diagram and critical behavior of the Si-Ge unmixing transition: A Monte Carlo study of a model with elastic degrees of freedom

Piercy; De'Bell; Pfnür, 1992:
Phase diagram and critical behavior of the adsorption system O/Ru(001): Comparison with lattice-gas models

Tavares; Telo da Gama MM.T.ixeira; Weis; Nijmeijer, 1995:
Phase diagram and critical behavior of the ferromagnetic Heisenberg fluid from density-functional theory

Jacobsen, J.Lykke.; Picco, M., 2002:
Phase diagram and critical exponents of a Potts gauge glass

Bartelt; Einstein; Wille, 1989 :
Phase diagram and critical properties of a two-dimensional lattice-gas model of oxygen ordering in YBa2Cu3Oz

Dorneich, A.; Hanke, W.; Arrigoni, E.; Troyer, M.; Zhang, S.C., 2002:
Phase diagram and dynamics of the projected SO(5) symmetric model of high- T(c) superconductivity

Patrick; Chen; Sher, 1987:
Phase diagram and local correlations in pseudobinary alloys

Ceder; Asta; Carter; Kraitchman; de Fontaine, D.M.nn; Sluiter, 1990:
Phase diagram and low-temperature behavior of oxygen ordering in YBa2Cu3Oz using ab initio interactions

Feng; Seehra, 1992:
Phase diagram and magnetic properties of the diluted fcc system NipMg1-pO

Zhang; Kim; Chan, 1986:
Phase diagram and phase transitions of monolayer and bilayer CF4 on graphite

Mehta, S.K.; Kawaljit, 2002:
Phase diagram and physical properties of a waterless sodium bis(2-ethylhexylsulfosuccinate)- ethylbenzene-ethyleneglycol microemulsion: an insight into percolation

Gompper; Kroll, 1995:
Phase diagram and scaling behavior of fluid vesicles

Althoff; Allen; Wentzcovitch; Moriarty, 1993:
Phase diagram and thermodynamic properties of solid magnesium in the quasiharmonic approximation

Hébert; Caillé; Bel Moufid A, 1993:
Phase diagram at T=0 of the one-dimensional chiral planar model in a twofold-anisotropy field

Raja; Shankar Rao DS.K.ishna Prasad S, 1992:
Phase diagram exhibiting a smectic-A-smectic-C-smectic-F meeting point

Kappler; Walker; Luettmer-Strathmann, 1995:
Phase diagram for UPd3 subject to symmetry-breaking stress and magnetic field

Straley; Barnett, 1993:
Phase diagram for a Josephson network in a magnetic field

Parker; Saslow; Gabay, 1991:
Phase diagram for a generalized fully frustrated triangular XY model

Zorzenon dos Santos RM; dos Santos RR, 1988:
Phase diagram for a random mixture of competing Ising anisotropies

Poniewierski; Sluckin, 1991:
Phase diagram for a system of hard spherocylinders

Poole; Essmann; Sciortino; Stanley, 1993:
Phase diagram for amorphous solid water

Zanchi; Bjelis; Montambaux, 1996:
Phase diagram for charge-density waves in a magnetic field

Chen; Cross, 1994:
Phase diagram for coherent vortex formation in the two-dimensional inviscid fluid in circular geometries

Leung; Chandler, 1994:
Phase diagram for excess electrons in simple fluids

Schulte; Holzapfel, 1993 :
Phase diagram for mercury up to 67 GPa and 500 K

Bauer; Dietrich, 2000:
Phase diagram for morphological transitions of wetting films on chemically structured substrates

Maiti; Falicov, 1992:
Phase diagram for sodium clusters

Devereaux; Scalettar; Zimanyi; Moon; Loh, 1995:
Phase diagram for splay glass superconductivity

Kumar; Kurkijarvi; Oja, 1985:
Phase diagram for spontaneous nuclear magnetic ordering in copper

Cruz; Phillips, 1994:
Phase diagram for strongly correlated doped trans-polyacetylene chains

Straley, 1994:
Phase diagram for the Gaudin model

Ariaratnam, J.T.; Strogatz, S.H., 2001:
Phase diagram for the Winfree model of coupled nonlinear oscillators

Kimel; Rikvold; Wang, 1992:
Phase diagram for the antiferromagnetic Blume-Capel model near tricriticality

Matthews; Strogatz, 1990:
Phase diagram for the collective behavior of limit-cycle oscillators

Shrimpton; Joós, 1990:
Phase diagram for the domain-wall lattice of krypton on graphite

Gabay; Garel; Parker; Saslow, 1989:
Phase diagram for the generalized Villain model

Yokota, 1989:
Phase diagram for the infinite-range transverse Ising spin-glass model

Arlett; Whitehead; MacIsaac; De'Bell, 1996:
Phase diagram for the striped phase in the two-dimensional dipolar Ising model

Zaluska-Kotur; Turski, 1990:
Phase diagram for the van der Waals-Potts fluid

Mukamel, E.A.; Shakhnovich, E.I., 2002:
Phase diagram for unzipping DNA with long-range interactions

Xu; Zhang, 1994:
Phase diagram in a two-dimensional Coulomb-gas model

Artuso; Borgonovi; Guarneri; Rebuzzini; Casati, 1992:
Phase diagram in the kicked Harper model

Shalaev, E.Y.; Steponkus, P.L., 1999:
Phase diagram of 1,2-dioleoylphosphatidylethanolamine (DOPE):water system at subzero temperatures and at low water contents

Tiwari; Glaberson, 1990:
Phase diagram of 3He-4He mixture films

Kim; Ma; Chan, 1993:
Phase diagram of 3He-4He mixture in aerogel

Zech; Lee; Keller; Blatter; Kes; Li, 1996 :
Phase diagram of Bi2.15Sr1.85CaCu2O8+ delta in the presence of columnar defects

Knebel; Eggert; Engelmann; Viana; Krimmel; Dressel; Loidl, 1996:
Phase diagram of CeCu2(Si1-xGex)2

Lee; Ju; Kim, 1994:
Phase diagram of KH2(P1-xAsx)O4 mixed crystals

Gibaud; Shapiro; Nouet; You, 1991:
Phase diagram of KMn1-xCaxF3 (x<0.05) determined by high-resolution x-ray scattering

Lucarelli, A.; Lupi, S.; Ortolani, M.; Calvani, P.; Maselli, P.; Capizzi, M.; Giura, P.; Eisaki, H.; Kikugawa, N.; Fujita, T.; Fujita, M.; Yamada, K., 2003:
Phase diagram of La2-xSrxCuO4 probed in the infared: imprints of charge stripe excitations

Dahn, 1991:
Phase diagram of LixC6

Dahn; McKinnon, 1985:
Phase diagram of LixMo

Klee; Knorr, 1991:
Phase diagram of N2:Ar:CO solid solutions

Mukamel; Hastings; Corliss; Zhuang, 1985:
Phase diagram of NdSb: Type-I fcc antiferromagnet in a magnetic field

Berg; Beirl; Krishnan; Markum; Riedler, 1996:
Phase diagram of Regge quantum gravity coupled to SU(2) gauge theory

Kitazawa; Nomura; Okamoto, 1996:
Phase diagram of S=1 bond-alternating XXZ chains

Adenwalla; Lin; Ran; Zhao; Ketterson; Sauls; Taillefer; Hinks; Levy; Sarma, 1990:
Phase diagram of UPt3 from ultrasonic velocity measurements

Park; Joynt, 1995:
Phase diagram of UPt3 in the E1g model

Boubcheur; Loison; Diep, 1996:
Phase diagram of XY antiferromagnetic stacked triangular lattices

Kremer; Robbins; Grest, 1986:
Phase diagram of Yukawa systems: Model for charge-stabilized colloids

Lee, J.W.; Cha, M.C.; Kim, D., 2001:
Phase diagram of a disordered boson Hubbard model in two dimensions

Patel; Chen; Kumar, 1993:
Phase diagram of a frustrated smectic liquid-crystal system and the absence of the incommensurate smectic-Ai2 phase

Cannas; Tsallis, 1992:
Phase diagram of a generalized t-J model: Renormalization-group approach

Honjo; Ohta; Matsushita, 1987:
Phase diagram of a growing succinonitrile crystal in supercooling-anisotropy phase space

Dasgupta; Valls, 2000:
Phase diagram of a hard-sphere system in a quenched random potential: A numerical study

Parlinski; Kwiecinski; Urbanski, 1992:
Phase diagram of a hexagonal model with incommensurate phases

Slotte, 1992:
Phase diagram of a lattice microemulsion model in two dimensions

Laradji; Guo; Grant; Zuckermann, 1991:
Phase diagram of a lattice model for ternary mixtures of water, oil, and surfactants

Lin; Shih; Bohanon; Ice; Dutta, 1990:
Phase diagram of a lipid monolayer on the surface of water

Müller, M., 2002:
Phase diagram of a mixed polymer brush

Sengupta; Marx; Nielaba; Binder, 1994:
Phase diagram of a model anticlustering binary mixture in two dimensions: A semi-grand-canonical Monte Carlo study

Alvarez, G.; Mayr, M.; Dagotto, E., 2003:
Phase diagram of a model for diluted magnetic semiconductors beyond mean-field approximations

Santoro; Manini; Parola; Tosatti, 1996:
Phase diagram of a model of correlated hopping of electrons in a lattice of Berry molecules

Christiansen; He; Habip; Bauer; Krueger; Martienssen, 1992:
Phase diagram of a modulated relaxation oscillator with a finite resetting time

Meyer; Anglès d'Auriac JC, 1995:
Phase diagram of a six-state chiral Potts model

Schöll-Paschinger, E.; Levesque, D.; Weis, J.J.; Kahl, G., 2001:
Phase diagram of a symmetric binary fluid in a porous matrix

Veerman; Frenkel, 1990:
Phase diagram of a system of hard spherocylinders by computer simulation

Sebastianes; Figueiredo, 1992:
Phase diagram of a trimodal random surface field

Sebastianes; Figueiredo, 1990:
Phase diagram of a trimodal random-field spin-S Ising model

Liu; Einstein; Sterne; Wille, 1995:
Phase diagram of a two-dimensional lattice-gas model of oxygen ordering in YBa2Cu3Oz with realistic interactions

Chen, S.; Büttner, H.; Voit, J., 2001:
Phase diagram of an asymmetric spin ladder

Aligia; Arrachea; Gagliano, 1995:
Phase diagram of an extended Hubbard model with correlated hopping at half filling

Eggert, S.; Gustafsson, D.P.; Rommer, S., 2001:
Phase diagram of an impurity in the spin-1/2 chain: two-channel Kondo effect versus Curie law

Grousson; Tarjus; Viot, 2001:
Phase diagram of an ising model with long-range frustrating interactions: A theoretical analysis

Folkins; Walker; Chen, 1991:
Phase diagram of betaine calcium chloride dihydrate in an applied electric field

Henkel; Seno, 1996:
Phase diagram of branched polymer collapse

Grumbach; Martin, 1996:
Phase diagram of carbon at high pressures and temperatures

Iota, V.; Yoo, C.S., 2001:
Phase diagram of carbon dioxide: evidence for a new associated phase

Lee; Lee; Kim, 2000:
Phase diagram of congested traffic flow: An empirical study

Troyer; Kontani; Ueda, 1996:
Phase diagram of depleted Heisenberg model for CaV4O9

Brey; Guinea, 2000:
Phase diagram of diluted magnetic semiconductor quantum wells

Ma; Figueiredo, 1996:
Phase diagram of disordered boson systems in the presence of random hopping

Riseborough; Hanggi, 1993:
Phase diagram of doped oxide superconductors: A slave-boson approach

Kapusta, 1990:
Phase diagram of electroweak theory

Zielinska; Mukamel; Steinberg; Fishman, 1986:
Phase diagram of externally modulated Rayleigh-Bénard system near the codimension-two point

Gompper; Kroll, 1994:
Phase diagram of fluid vesicles

Küpfer; Gordeev; Jahn; Kresse; Meier-Hirmer; Wolf; Zhukov; Salama; Lee, 1994:
Phase diagram of flux creep in melt-textured and single-crystalline YBa2Cu3O7- delta

Marenduzzo, D.; Trovato, A.; Maritan, A., 2001:
Phase diagram of force-induced DNA unzipping in exactly solvable models

Dijkstra, M.; van Roij, R.; Evans, R., 2002:
Phase diagram of highly asymmetric binary hard-sphere mixtures

Clement-Cottuz; Amokrane; Regnaut, 2000:
Phase diagram of highly asymmetric binary mixtures: A study of the role of attractive forces from the effective one-component approach

Kumada, N.; Terasawa, D.; Shimoda, Y.; Azuhata, H.; Sawada, A.; Ezawa, Z.F.; Muraki, K.; Saku, T.; Hirayama, Y., 2002:
Phase diagram of interacting composite fermions in the bilayer nu=2/3 quantum hall effect

Almeida; Mills, 1995:
Phase diagram of magnetic multilayers: The role of biquadratic exchange

Fygenson; Braun; Libchaber, 1994:
Phase diagram of microtubules

Bezryadin; Buzdin; Pannetier, 1995:
Phase diagram of multiply connected superconductors: A thin-wire loop and a thin film with a circular hole

Sfatos; Gutin; Shakhnovich, 1993:
Phase diagram of random copolymers

Bak; Kleban; Unertl; Ochab; Akinci; Bartelt; Einstein, 1985:
Phase diagram of selenium adsorbed on the Ni(100) surface: A physical realization of the Ashkin-Teller model

Chavanis, P.H.; Ispolatov, I., 2002 :
Phase diagram of self-attracting systems

Broughton; Li, 1987:
Phase diagram of silicon by molecular dynamics

Radovic; Ledvij; Dobrosavljevic-Grujic, 1991:
Phase diagram of superconducting-normal-metal superlattices

Bergerhoff; Freire; Litim; Lola; Wetterich, 1996:
Phase diagram of superconductors from nonperturbative flow equations

Antonevych, O.; Forstmann, F.; Diaz-Herrera, E., 2002:
Phase diagram of symmetric binary fluid mixtures: first-order or second-order demixing

Shevchenko, 1994:
Phase diagram of systems with pairing of spatially separated electrons and holes

Fang; Solovyev; Terakura, 2000:
Phase diagram of tetragonal manganites

Brussaard, P.; Fisher, S.N.; Guénault, A.M.; Hale, A.J.; Mulders, N.; Pickett, G.R., 2001:
Phase diagram of the A and B phases of superfluid 3He in aerogel

Yamanaka; Hatsugai; Kohmoto, 1994:
Phase diagram of the Ashkin-Teller quantum spin chain

Chau, H.F.; Wan, K.Y., 2002:
Phase diagram of the Biham-Middleton-Levine traffic model in three dimensions

Rosengren; Lapinskas, 1993:
Phase diagram of the Blume-Emery-Griffiths model on the honeycomb lattice calculated by the cluster-variation method

Tétot; Kudrnovsk; Pasturel; Drchal; Weinberger, 1995:
Phase diagram of the Cu-Pd surface alloy: A first-principles calculation

Motta; Christensen, 1991:
Phase diagram of the Fe1-xCoxSi2 alloy in the fluorite form

Little; Zangwill, 1992:
Phase diagram of the Frenkel-Kontorova-Devonshire model

Coppersmith; Yu, 1989:
Phase diagram of the Hubbard model: A variational wave-function approach

Kaufman; Touma, 1994:
Phase diagram of the Ising model on percolation clusters

Berker; Hui, 1993:
Phase diagram of the Ising model on the square lattice with crossed diagonal bonds

Gocksch; Shen, 1992:
Phase diagram of the N=2 Kazakov-Migdal model

Yamanaka; Hatsugai; Kohmoto, 1993:
Phase diagram of the S=1/2 quantum spin chain with bond alternation

Novais, E.; Miranda, E.; Castro Neto, A.H.; Cabrera, G.G., 2002:
Phase diagram of the anisotropic Kondo chain

Shapira; Klein; Adler; Aharony; Harris, 1994:
Phase diagram of the dilute Ising spin glass in general spatial dimension

Berret; Bostoen; Hennion, 1992:
Phase diagram of the dipolar glass K1-x(NH4)xI

Dongen, 1996:
Phase diagram of the extended Hubbard model at weak coupling

Cannon; Fradkin, 1990:
Phase diagram of the extended Hubbard model in one spatial dimension

Kuroki; Kusakabe; Aoki, 1994:
Phase diagram of the extended attractive Hubbard model in one dimension

Gulácsi; Van Beijeren, H.L.vi, 1993:
Phase diagram of the five-vertex model

Thijssen, 1989:
Phase diagram of the frustrated XY model on a triangular lattice

Gonnella; Maritan, 1993:
Phase diagram of the frustrated gauge-invariant Ising model

Dagotto; Moreo, 1989:
Phase diagram of the frustrated spin-1/2 Heisenberg antiferromagnet in 2 dimensions

Chubukov; Gagliano; Balseiro, 1992:
Phase diagram of the frustrated spin-1/2 Heisenberg antiferromagnet with cyclic-exchange interaction

Xu; Ting, 1990:
Phase diagram of the frustrated square Heisenberg lattice based upon a modified spin-wave theory

Scalettar; Scalapino; Sugar; Toussaint, 1989 :
Phase diagram of the half-filled 3D Hubbard model

Blount; Varma; Aeppli, 1990:
Phase diagram of the heavy-fermion superconductor UPt3

Shenoy; Gupte, 1988:
Phase diagram of the lattice superconductor

Guerrero; Noack, 1996:
Phase diagram of the one-dimensional Anderson lattice

Tsunetsugu; Sigrist; Ueda, 1993:
Phase diagram of the one-dimensional Kondo-lattice model

Tsuchiizu, M.; Furusaki, A., 2002:
Phase diagram of the one-dimensional extended Hubbard model at half filling

Penc; Mila, 1994:
Phase diagram of the one-dimensional extended Hubbard model with attractive and/or repulsive interactions at quarter filling

Hirsch, 1985:
Phase diagram of the one-dimensional molecular-crystal model with Coulomb interactions: Half-filled-band sector

Ogata; Luchini; Sorella; Assaad, 1991:
Phase diagram of the one-dimensional t-J model

Usadel; Büttner; Kopec, 1991:
Phase diagram of the quantum Ising spin glass in a transverse field

de Souza AM, 1993:
Phase diagram of the quantum anisotropic Heisenberg model on a self-dual hierarchical lattice

Saguia, A.; Boechat, B.; Continentino, M.A., 2002:
Phase diagram of the random Heisenberg antiferromagnetic spin-1 chain

Fisch, 1992:
Phase diagram of the random chiral model

Nowotny, T.; Patzlaff, H.; Behn, U., 2002:
Phase diagram of the random field Ising model on the Bethe lattice

Sebastianes; Saxena, 1987:
Phase diagram of the random-field Ising model with a trimodal distribution

de Oliveira MJ, 1991:
Phase diagram of the spin-1/2 Heisenberg antiferromagnet on a square lattice with nearest- and next-nearest-neighbor couplings

Grollau, S., 2002:
Phase diagram of the spin-3/2 Blume-Capel model in three dimensions

Parlinski, 1993:
Phase diagram of the square-lattice model with 1q and 2q incommensurate modulations

Khachaturyan; Semenovskaya; Morris, 1988:
Phase diagram of the superconducting oxide YBa2Cu3O6+ delta

Barford; Lu, 1991:
Phase diagram of the t-J model: A semiclassical calculation

Houlrik; Jensen, 1986:
Phase diagram of the three-state chiral clock model studied by Monte Carlo renormalization-group calculations

Milman; Hauser; Figueiredo, 1991:
Phase diagram of the transverse Ising model in a random field

Mazzeo; Carlon; van Beijeren H, 1995:
Phase diagram of the two component body-centered solid-on-solid model

Nobre, F.D., 2001:
Phase diagram of the two-dimensional +/-J Ising spin glass

Yi; Zhang; Canright, 1994:
Phase diagram of the two-dimensional Anderson-Hubbard model

Dasgupta; Halley, 1993:
Phase diagram of the two-dimensional disordered Hubbard model in the Hartree-Fock approximation

Scalettar; Loh; Gubernatis; Moreo; White; Scalapino; Sugar; Dagotto, 1989:
Phase diagram of the two-dimensional negative-U Hubbard model

Poilblanc, 1995:
Phase diagram of the two-dimensional t-J model at low doping

Zhitomirsky; Ueda, 1996:
Phase diagram of the unconventional superconductor UPt3 in the weak-crystal-field model

Mirasso; Massidda, 1989:
Phase diagram of the "2+4" model in a mean-field approximation without correlations

Carriço; Camley; Stamps, 1994:
Phase diagram of thin antiferromagnetic films in strong magnetic fields

Abanov; Kalatsky; Pokrovsky; Saslow, 1995:
Phase diagram of ultrathin ferromagnetic films with perpendicular anisotropy

Janz; Lüpke; van Driel HM, 1993:
Phase diagram of vicinal Cu(111) surfaces as determined by second-harmonic generation

Pehlke; Tersoff, 1991:
Phase diagram of vicinal Si(001) surfaces

Tupitsyn; Wallin; Rosengren, 1996:
Phase diagram of vortices in double-layer quantum Hall systems

Parts; Karimäki; Koivuniemi; Krusius; Ruutu; Thuneberg; Volovik, 1995:
Phase diagram of vortices in superfluid 3He-A

Martínez-Miranda; Kortan; Birgeneau, 1987:
Phase diagram, fluctuations, and phase transitions near the liquid-crystal nematic-smectic-A-smectic-C multicritical point

Schulz, 1986:
Phase diagrams and correlation exponents for quantum spin chains of arbitrary spin quantum number

Landau; Binder, 1985:
Phase diagrams and critical behavior of Ising square lattices with nearest-, next-nearest-, and third-nearest-neighbor couplings

Fischer; Furrer; Kaldis; Kim; Kjems; Levy, 1985:
Phase diagrams and magnetic excitations in holmium phosphide

Roussel; Buisine; Maschke; Coqueret; Benmouna, 2000:
Phase diagrams and morphology of polymer dispersed liquid crystals based on nematic-liquid-crystal-monofunctional-acrylate mixtures

Leatherman; Diehl, 1996:
Phase diagrams and rotated incommensurate phases of K, Rb, and Cs adsorbed on Ag(111)

Sarmento; Kaneyoshi, 1993:
Phase diagrams and tricritical behavior of a diluted spin-1 transverse Ising model in a random field

Grushko; Gordon; Vagner; Wyder, 1992:
Phase diagrams at diamagnetic phase transitions

Carneiro; de Mello EV, 1987:
Phase diagrams for 3He-4He and H2-D2 mixtures adsorbed on graphite

Niskanen, 1986:
Phase diagrams for submonolayer films on weakly corrugated substrates

Bowling; Collings; Booth; Goodby, 1993:
Phase diagrams for the blue phases of highly chiral liquid crystals

Balcerzak; Bobák, 1993:
Phase diagrams for the disordered Ising model with second-neighbor interactions

Harris; Aharony, 1989:
Phase diagrams for the randomly diluted resistor network and XY model

Giordano, F.; Rossi, A., 2000:
Phase diagrams in the binary system

Lii; Wang, 1995:
Phase diagrams of a diluted Ising thin ferromagnetic film in a transverse field

Kaneyoshi; Li , 1987:
Phase diagrams of a disordered, ferromagnetic, binary Ising system

Hong; Fultz, 1995:
Phase diagrams of bcc alloys at low temperatures with ballistic atom movements

Caflisch; Blankschtein, 1986:
Phase diagrams of cubic systems under uniaxial quadratic symmetry-breaking fields

Khusid, B.; Acrivos, A., 2002:
Phase diagrams of electric-field-induced aggregation in conducting colloidal suspensions

Toledano; Figueiredo Neto AM; de Sant'Ana ZA, 2000:
Phase diagrams of lyotropic cholesteric fluids

Lyra; da Silva CR, 1992:
Phase diagrams of magnetically disordered bilayers

Roussel, Fédérick.; Maschke, U.; Buisine, J-Marc.; Coqueret, X.; Benmouna, M., 2002:
Phase diagrams of monomer and uv-cured difunctional-acrylate-nematic-liquid-crystal systems

Dinsmore; Yodh; Pine, 1995:
Phase diagrams of nearly-hard-sphere binary colloids

Zubkus; Tornau; Lapinskas; Kundrotas, 1991:
Phase diagrams of oxygen ordering in high-temperature superconductors RBa2Cu3O7-x

Bauer; Riesenhuber; Geisel, 1996:
Phase diagrams of self-organizing maps

Schaub; Mukamel, 1985:
Phase diagrams of systems exhibiting incommensurate structures

Strandberg, E.; Sparrman, T.; Lindblom, G., 2001:
Phase diagrams of systems with cationic alpha-helical membrane-spanning model peptides and dioleoylphosphatidylcholine

Ni; Iwata, 1995:
Phase diagrams of the Blume-Emery-Griffiths model for semiconducting alloy systems (ABD2)1-x(CD)2x or

Nagai, 1985:
Phase diagrams of the corner cubic Heisenberg model and its site-diluted version on a triangular lattice: Renormalization-group treatment

Zamora; Pérez Alcázar GA.B.hórquez; Rosales Rivera, A.P.ascak, 1995:
Phase diagrams of the diluted and random-bond Ising model

Sano; Ono, 1995:
Phase diagrams of the electronic state of the one-dimensional d-p model

Goldschmidt; Xu, 1985:
Phase diagrams of the random-field Potts model in three dimensions

Wang; Lee; Kimel, 1987:
Phase diagrams of the spin-1 Ising Blume-Emery-Griffiths model: Monte Carlo simulations

Giamarchi; Lhuillier, 1991:
Phase diagrams of the two-dimensional Hubbard and t-J models by a variational Monte Carlo method

Tejero; Daanoun; Lekkerkerker; Baus, 1994:
Phase diagrams of "simple" fluids with extreme pair potentials

Hirvonen, T.P.; Aalto, H.; Pyykkö, I.; Juhola, M., 1997:
Phase difference of vestibulo-ocular reflex in head autorotation test

Wagner; Brecha; Schenzle; Walther, 1992:
Phase diffusion and continuous quantum measurements in the micromaser

Grondalski, J.; Alsing, P.M.; Deutsch, I.H., 2001:
Phase diffusion as a model for coherent suppression of tunneling in the presence of noise

Blackburn; Gronbech-Jensen, 1996:
Phase diffusion in a chaotic pendulum

D'Alessandro; Politi; Arecchi, 1989:
Phase diffusion in chaotic laser dynamics

Wagner; Brecha; Schenzle; Walther, 1993:
Phase diffusion, entangled states, and quantum measurements in the micromaser

Schwarzer, R., 2002:
Phase discrimination by automated BKD

Schieve; McGowan, 1993:
Phase distribution and linewidth in the micromaser

Vogel; Schleich, 1991:
Phase distribution of a quantum state without using phase states

Hillery; Freyberger; Schleich, 1995:
Phase distributions and large-amplitude states

Brand, 1985:
Phase dynamics for incommensurate nonequilibrium systems

Brand; Wesfreid, 1989 :
Phase dynamics for pattern-forming equilibrium systems under an external constraint

Brand, 1985:
Phase dynamics for spiraling Taylor vortices

Brattkus; Misbah, 1990:
Phase dynamics in directional solidification

Fourtune; Rappel; Rabaud, 1994:
Phase dynamics near a parity-breaking instability

Meng; Chai; Zhang, 1992:
Phase dynamics of coherent light in the M-photon Jaynes-Cummings model

Hagberg; Meron; Passot, 2000:
Phase dynamics of nearly stationary patterns in activator-inhibitor systems

Roth; Lücke; Kamps; Schmitz, 1994:
Phase dynamics of patterns: The effect of boundary-induced amplitude variations

Wu; Andereck, 1991:
Phase dynamics of wavy vortex flow

Brand, 1987:
Phase dynamics with a material derivative due to a flow field

Qu; Hu; Yang; Qin, 1995:
Phase effect in taming nonautonomous chaos by weak harmonic perturbations

Bauer; Kastner; Arnau; Salin; Fainstein; Ponce; Echenique, 1992:
Phase effect in the energy loss of H projectiles in Zn targets: Experimental evidence and theoretical explanation

Arnau; Bauer; Kastner; Salin; Ponce; Fainstein; Echenique, 1994:
Phase effect in the energy loss of hydrogen projectiles in zinc targets

Kasumova, R.J., 2002:
Phase effects at fifth-harmonic generation

Silverans; Borghs; D.B.sschop P.V.n Hove M, 1985:
Phase effects in bichromatic field interactions with a two-level atom

Fowler, C.G.; Mikami, C.M., 1996:
Phase effects on the middle and late auditory evoked potentials

Kibble; Vilenkin, 1995:
Phase equilibration in bubble collisions

Foffi, G.; McCullagh, G.D.; Lawlor, A.; Zaccarelli, E.; Dawson, K.A.; Sciortino, F.; Tartaglia, P.; Pini, D.; Stell, G., 2002:
Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization

Umantsev; Olson, 1993:
Phase equilibria and transformations in adiabatic systems

Sokolowska; Moscicki, 2000:
Phase equilibria in an athermal solution of platelike particles

Wnek; Moscicki, 1996:
Phase equilibria in solutions of disklike particles

Wensink, H.H.; Vroege, G.J., 2002:
Phase equilibria in systems of hard disks with thickness polydispersity

Glotova, I.K.; Pavlovskaia, G.E.; Lashko, N.P.; Antonov, I.A.; Tolstoguzov, V.B., 1993:
Phase equilibria in water-defatted milk proteins-carboxymethylcellulose sodium salt systems

Dubey; O'Shea, 1994:
Phase equilibria of Lennard-Jones dipolar plus quadrupolar fluids by Gibbs-ensemble Monte Carlo simulation

Kyu; Chiu, 1996:
Phase equilibria of a polymer-smectic-liquid-crystal mixture

Strange, J.H.; Allen, S.G.; Stephenson, P.C.; Matveeva, N.P., 1996:
Phase equilibria of absorbed liquids and the structure of porous media

Yan, Q.; de Pablo, J.J., 2002:
Phase equilibria of charge-, size-, and shape-asymmetric model electrolytes

Yan, Q.; de Pablo, J.J., 2001:
Phase equilibria of size-asymmetric primitive model electrolytes

Page; Monson, 1996:
Phase equilibrium in a molecular model of a fluid confined in a disordered porous material

Ji, Y.; Heiblum, M.; Sprinzak, D.; Mahalu, D.; Shtrikman, H., 2000:
Phase evolution in a Kondo-correlated system

Carini; Feng; Li; Ruffini, 1992:
Phase evolution of the photon in Kerr spacetime

Jeong, J.H.; Goldenfeld, N.; Dantzig, J.A., 2001:
Phase field model for three-dimensional dendritic growth with fluid flow

Lue; Brenner, 1993:
Phase flow and statistical structure of Galton-board systems

Meingast, C.; Pasler, V.; Nagel, P.; Rykov, A.; Tajima, S.; Olsson, P., 2001:
Phase fluctuations and the pseudogap in YBa(2)Cu(3)O (x)

Orr; Clem; Jaeger; Goldman, 1986:
Phase fluctuations in Josephson junctions

Rauf; Zubairy, 1987:
Phase fluctuations in a degenerate parametric amplifier

Orszag; Saavedra, 1991:
Phase fluctuations in a laser with atomic memory effects

Andersen, J.O.; A.K.awaja, U.; Stoof, H.T.C., 2002:
Phase fluctuations in atomic Bose gases

Peng; Li, 1992:
Phase fluctuations in the Jaynes-Cummings model with and without the rotating-wave approximation

van der Zant HS.W.bster; Romijn; Mooij, 1990:
Phase fluctuations in two-dimensional superconducting weakly coupled wire networks

Wienold, J.; Jentoft, R.E.; Ressler, T., 2001:
Phase formation during the decomposition of ammonium heptamolybdate--an in situ XAFS and XRD investigation

Karpe; Larsen; Bottiger, 1992:
Phase formation induced by ion irradiation and electrical resistivity of aluminum-3d-transition-metal alloys

Denier van der Gon AW.T.omp, 1992:
Phase formation sequence and domain structure: A low-energy-electron-microscopy study of the Si(111)-( sqrt 3 x sqrt 3 )Ag surface

Schleich; Bandilla; Paul, 1992:
Phase from Q function via linear amplification

Mobley, C.D.; Sundman, L.K.; Boss, E., 2002:
Phase function effects on oceanic light fields

Dalidovich, D.; Phillips, P., 2002:
Phase glass is a Bose metal: a new conducting state in two dimensions

Scholl, J.F.; Dereniak, E.L.; Descour, M.R.; Tebow, C.P.; Volin, C.E., 2003:
Phase grating design for a dual-band snapshot imaging spectrometer

Brüssler; Metzner; Husemann; Lewerenz, 1988:
Phase identification in the Cu-In-S system by gamma - gamma perturbed angular correlations

Small, J.A.; Michael, J.R., 2001:
Phase identification of individual crystalline particles by electron backscatter diffraction

Love; Scott, 2000:
Phase identification of microfeatures using EPMA methods, especially high-resolution X-ray spectroscopy

Sinha, S.; Oshiro, T.; Sinha, U.; Lufkin, R., 1997:
Phase imaging on a .2-T MR scanner: application to temperature monitoring during ablation procedures

Lakshmi; Swain, 1990:
Phase in the correlated-emission laser

Dai, H.; Nguyen, Q.; Kidd, G.; Feth, L.L.; Green, D.M., 1996:
Phase independence of pitch produced by narrow-band sounds

Micheli-Tzanakou, E.; Pavlopoulos, S., 1997:
Phase information in visual evoked potentials

Chen, Y.; Broschat, S.L.; Flynn, P.J., 1996:
Phase insensitive homomorphic image processing for speckle reduction